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ABSTRACT 
Zeolites to Peptides: Statistical Mechanics Methods for 
Structure Solution and Proper ty Evaluation 
by 
Ramdas S. Pophale 
Methods in statistical mechanics are used to study structure and properties of zeolites 
and peptides. A Monte Carlo method is applied to solve structure of a newly synthesized 
zeolite. Understanding the structure of a zeolite could lead to optimization of chemical 
processes it is involved in. Dielectric constant and elastic modulus are calculated using 
a molecular dynamics method for a pure silica zeolite with and without the structure 
directing agent used in its synthesis. These properties are of interest due to the poten-
tial use of this zeolite as low dielectric constant material in manufacturing integrated 
circuits. Results of four methods probing energy landscapes in peptides are compared 
iii 
for four cyclic peptides. Their ability to equilibrate structural properties and their rel-
ative speeds are important in their ability to simulate complex structures. A docking 
study is carried out to probe interactions between two proteins, Gripto and Snail, and 
E-cadherin promoter. The study supports experimental evidence that Cripto is involved 
in expression of E-cadherin through a promoter priming mechanism. Finally, the use of 
computational models in the design of better vaccines is illustrated through an example 
of Influenza. 
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Chapter 1 
Introduction 
The main goal of the research topics included in this Doctoral Thesis is the structure 
determination of biological and synthetic systems using methods based in statistical 
mechanics. The thesis is organized in five different chapters. Each chapter documents 
findings from a different research project, and is self-contained. 
The first chapter describes efforts in solving the three dimensional structure of a 
newly synthesized zeolite from powder diffraction data. Monte Carlo techniques, such as 
configurational bias, and parallel tempering were used to solve for the structure. Solution 
thus obtained was refined using a non-linear, least squares fit method called the Rietveld 
method. Two different approaches were tried to model the non-framework atoms from 
an organic template molecule. The work was able to generate geometrically feasible 
structures for the zeolite in question. Useful insights were obtained regarding handling 
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of the impurity within the powder sample in order to facilitate further efforts towards 
finding the correct solution. 
The second chapter documents determination of dielectric constant and elastic mod-
ulus for a single crystal zeolite. Thin film zeolites have emerged as attractive substrates 
for applications in the semiconductor industry, where manufacturers of integrated cir-
cuits are on the look out for low dielectric constant materials. An increase in porosity is 
often cited as a way to reduce the dielectric constant, however, with increasing porosity, 
a decrease in mechanical strength becomes an issue. A molecular dynamics approach was 
used to study the calculate these properties for ZSM-5. Also observed, was the effect of 
a structure directing organic molecule used during zeolite synthesis on these properties. 
Chapter three compares four different combinations of simulation techniques for a 
set of four cyclic peptides. Cyclic peptides tend to have rough free energy profiles with 
local energy minima are often separated by high energy barriers. Simple Monte Carlo 
or molecular dynamics methods by themselves fail to sample the relevant configurations 
3 
from a distribution of interest. A combination of these methods with advanced techniques 
such as rebridging and parallel tempering stands a better chance at equilibrating these 
systems. The rebridging move improves the equilibration in all the cases. A generalized 
Born model is implemented to account for the solvent effects and is tested for a simple 
dialanine peptide. 
Chapter four describes results of a docking study. Homologes of protein Cripto and 
protein Snail, and the E-cadherin promoter were docked using a docking program. It was 
found that Cripto and Snail favourably bind E-cadherin near the so called E-box. The 
result supports experimental observations, which show Cripto as a regulating agent for 
the expression of E-cadherin through a promoter (Snail) priming mechanism. 
The final chapter talks about design and improvement in efficacy of Influenza vaccine. 
A new parameter shows a better correlation between the dominant virus strain and the 
vaccine than the traditional measures of antigenic distance. A study that combines 
multiple-strain avian influenza model and the new parameter is able to reproduce the 
4 
observed viral fixation rates and with isolates data from World Health Organization 
FluNet Global Influenza Surveillance Network. 
Chapter 2 
Structure Solution of Zeolite CLS-3 
2.1 Introduction 
The derivation of an atomic-scale model of the framework crystal structure of a newly 
synthesized zeolite is a nontrivial task [2]. Most zeolite samples are poly-crystalline in 
nature. This, along with typical crystallite sizes (below 5/xm) makes structure solution a 
difficult process. Many known zeolite structures are a result of physical model building 
efforts. Conventional crystallographic methods have yielded solution in only a limited 
number of cases [3]. This approach requires a high quality scattering data set for a 
successful solution. Such data set are not usually obtainable from zeolite samples, ex-
plaining the limited applicability of this approach. Of late, electron diffraction methods 
[4, 5] have been used to solve a few zeolite structures, however, this approach is laborious. 
Charge-flipping methods have shown substantial promise in recent years [6]. 
In this chapter, I document my efforts to solve the structure of a newly synthesized 
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zeolite, CLS-3, from X-ray powder diffraction data collected at a synchrotron source. 
This chapter is divided into two sections. In section 1, I explain the process of structure 
determination of the zeolite using ZEFSAII (zeolite framework solution), our in-house 
method. In section 2, I describe the refinement process used to validate the structure 
obtained from ZEFSAII. 
2.2 ZEFSAII 
ZEFSAII is a direct, real-space method [2] that applies powerful Monte Carlo tech-
niques to the problem of zeolite structure solution via powder diffraction data. ZEFSAII 
stands for zeolite framework solution. It requires easily available powder diffraction data 
and little preconceived bias on behalf of the researcher. At its heart lies the key step of 
defining a cost function or a figure of merit that is the function of the atomic positions 
within the crystalline unit cell and that is minimized by the structure corresponding to 
the experimental material. The figure of merit is defined for a given zeolite sample with 
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known unit cell size, cell parameters, symmetry, and density. By definition, the global 
minimum of the figure of merit should correspond to the structure of the zeolite sample 
under investigation. Locating this global minimum is a fundamentally challenging prob-
lem, owing to the presence of multitude of local minima and large barriers in the cost 
function. Two versions of the method are available, namely, ZEFSAI and ZEFSAII. The 
major difference between the two methods lies in the manner in which they go about min-
imizing the zeolite figure of merit. ZEFSAI combines a simple Metropolis perturbation 
step with a simulated annealing procedure. It has a nearly 90% success rate on zeolites 
with 6 or fewer crystallographically-distinct T atoms. A number of different groups have 
used this method to solve new zeolite structures [7, 8, 9, 10, 11]. However, in case of 
more complex structures, the method ends up generating multiple hypothetical struc-
tures, often failing to find the correct one. ZEFSAII, on the other hand, combines biased 
Monte Carlo moves and simulated annealing in order to overcome the barriers. In the 
most difficult cases (crystallographically-distinct T atoms > 10), the method of parallel 
8 
tempering is used to overcome the barriers in the cost function, and proves superior to 
simulated annealing. ZEFSAII can solve all of the known zeolite structures, and it was 
employed in this research. In the next section I will describe composition of the figure of 
merit and the origin of the terms therein in some detail. 
2.2.1 Figure of Merit 
In ZEFSAII there are nuniqUe atoms placed in the unit cell. Each of the nsymm operators 
when applied to an unique T-atom generates an atom position, so there can be at most 
"•unique x "symm positions of atoms in the unit cell. The cell parameters, the space-group 
symmetry, and the number of unique T-atoms are kept constant. This leaves positions 
of the T-atoms as the only variables. The figure of merit is defined as follows: 
H = 
+ auHu + OiucHuc + aNB-^ NB + ^PXD-^PXD + «PND-^PND (2.1) 
The lower the value of H, the more the particular arrangement of T-atoms resembles 
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a zeolite of the given cell size, symmetry, and density. Each term in H represents a 
particular contribution, and the ct; are the relative weights. These weights are optimized 
according to the rate of success of the method on several trial structures (over a decade 
ago) and are kept fixed. One begins with a random configuration of T-atoms and seeks 
the minimum of H by moving the T-atoms suitably. Since the space-group symmetry is 
enforced, all symmetry-related T-atoms move collectively. Also, the crystalline order is 
enforced so the variables are limited to asymmetric unit of a single unit cell. 
Three different types of terms contribute to Eq. 1. These are, the geometric terms, 
the density terms, and the diffraction terms. The first three terms of H are geometric 
contributions that are obtained from 32 known high silica zeolites by histogramming 
the T-T distances, and the T-T-T angles [12, 13]. As expected for tetrahedrally coor-
dinated species, the T-T distances are distributed around 3.1 A and the T-T-T angles 
are distributed around 109.5°. The term <T-T-T> represents the average over all angles 
around a particular T-atom. 
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The HUB and Huc terms account for the 4-connectedness of silicates. These terms 
are defined to be nonzero and positive whenever a T-atom is found to have greater than 
or fewer than 4 first neighbours, respectively. A neighbour is defined as an atom that is 
within 4 A . If there are fewer than 4 neighbours, a progressively higher weight is assigned 
to the atom. In the case where an atom is found to have greater than 4 neighbours, a list 
of all N neighbours is prepared. From this list, 4 of the atoms are selected as connected 
neighbours. For the rest, a repulsive potential energy term is included. The list of 
N neighbours is searched exhaustively for the combination of 4 connected and N — 4 
unconnected atoms so as to get a minimum energy associated with the central T-atom. 
The HM term favours merging. Whenever a particular atom sits on a special position, 
meaning a position that is invariant under symmetry operations other than the identity, 
merging is favoured. As ZEFSAII assigns positions to atoms in a random manner, the 
probability of finding an atom exactly on a special position is very low. Therefore, a 
merging range is defined with ru = 0.8 A. When two or more symmetry related atoms 
11 
fall within this range, they are merged, as in replaced by a single atom at the position 
of their center of mass. Hu allocates a negative favourable energy to the merged atoms 
that is linearly proportional to the distance between original and the merged position 
known as the merging distance. Merging is necessary whenever the number of T-atoms 
derived from the experimental density, n0 is less than the number created by symmetry, 
u^nique x "-syrnm- Merging is not allowed whenever no = nunjque x nsymm. In order that 
atoms do not collapse on a highly symmetrical position, thus, lowering the density below 
the, observed one, a term HD = (nx — no)2 is included to enforce the observed density. 
Here, nT is the actual number of atoms in the unit cell after merging. 
2.2.2 Intensity Calculations 
The experimental information available about the zeolite is incorporated into the 
figure of merit through the diffraction terms, ifpxD and i/pND- A typical diffraction 
powder X-ray diffraction (PXD) pattern is shown in Fig. 1. To our disposal we have 
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a list of Bragg reflections with Miller indices (hkl) and relative intensities. Using the 
standard formulas [14], one can calculate the relative intensities for a given arrangement 
of atoms in a unit cell and for the same list of reflections. In arbitrary units, the intensity 
of a reflection is given by the following equation as 
I(hkl)=p(e)\Fhkl\2, (2.2) 
where 20 is the angle of the Bragg reflection, and the term p(6) is the polarization term 
given byp(0) = [1+ cos2(20)]/[2sin(0) sin(20)] for X-rays and p{9) = l/[2sin(0)sin(20)] 
for neutrons. The scattering amplitude, Fhki, is given by the following equation as 
Fhki = J2 /7(k)ojexp(-JBik2/4)exp(27rik.xj), (2.3) 
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where 
k = hbi + kb2 + lb3 (2.4) 
Xj = m!pan + mf)SL2 + mf^a3 (2.5) 
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Here, a^  represent the crystal axes, the m,j(i) represent the crystallographic coordi-
nates, and the 6* represent the reciprocal lattice vectors. The /j(k) are the form factors 
for the given atomic species [15]; the Oj are the occupancy numbers, which account for 
cell positions not always filled with an atom or filled with atoms of different types with 
different probabilities; and the Bj are the Debye-Waller factors that account for thermal 
vibrations in the lattice. Since the crystal structure is not known, the information about 
the occupancies or the Debye-Waller factors is unavailable. Therefore, Oj and Bj are set 
to 1 and 0.5. 
The presence of multiple reflections at angles closer than the resolution is one of the 
major challenges to the use of powder data. In order to compare calculated intensities 
with the observed ones, a composite peak is put at the average angle with all the intensity 
of the multiple reflections into the composite peak. 
How well a particular configuration of T-atoms matches against the experimental 
14 
powder pattern is measured via the following quantity. 
-^i{Iobs_sIcalc)2/u. 
HPXD = T7 min 
I\ 8 
(2.6) 
Here, i runs over all the N peaks, composite or otherwise. The w\ are the weights, and 
s is a global scaling factor. The intensities are relative, and the experimental intensities 
are scaled so that the largest one is 1000. The expression for the global scaling factor, 
"min Ik 
Ei(irbsifalc)M
 (97, 
£i(i?alc)2M ' 
The weights uj{ account for uncertainty in the experimental as well as calculated data 
both of which are proportional to the intensity itself. 
It is important to choose weights in Equation 1 in a judicious manner. The geometric 
potentials in equation 1 are smooth, so are the density terms. However, the diffraction 
terms have a rough energy profile in that they are quite sensitive to the positions of the 
atoms. ZEFSAII mixes the geometric terms with the diffraction terms in a manner so 
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as to smooth out the roughness in the diffraction terms. Table 2.1 lists the values of 
various weights in the figure of merit. The rate of success in finding structure solution is 
independent of small changes in the parameters [2]. 
Finally, the merging term Hu is kept fixed at zero at ru = 0.8A and -300 at TM = 0A. 
2.2.3 Sampling the figure of merit 
In this section I will describe the Monte Carlo algorithm that was used to sample the 
figure of merit. The traditional Metropolis method does not use information about the 
energy landscape around the current configuration while proposing trial moves. This is an 
inefficient strategy for sampling the phase space according to the Boltzmann distribution, 
as most of the moves try to bring the system to high energy regions of the configuration 
space, and end up being rejected. The biased Monte Carlo scheme has been shown 
to improve the sampling efficiency [16, 17, 18]. This method probes the configurations 
around the current one and proposes moves that are more likely to be accepted. In 
Table 2.1 Weights for terms in the figure of merit. 
weight 
OtT—T 
<^T—T—T 
Q ! < T - T - T > 
&D 
aM 
0iuc 
" N B 
ttPXD 
Q!PND 
value 
1 
1 
2 
30 
1 
1 
1.5 
1-2 
1-2 
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ZEFSAII, the biased move proceeds as follows. 
Let the current configuration be A\. From the following Gaussian distribution, A; 
random displacements, Ax{, are extracted that propose k new configurations, J3j. 
int exP[-Ax*/(2a2)} 
A Rosenbluth weight W is constructed as 
W(n) = £ ) e x p [ - ^ ( B i ) ] I (2.9) 
i = l 
and a normalized probability is assigned to each configuration JBj as 
Pr* = exp[-/3^(B0]/W(n). (2.10) 
One of these configurations, Bn, is selected randomly according to its probability. 
The configuration Bn then becomes the proposed move. The lower the energy is, the 
more likely it is for the corresponding configuration to be selected. In order to satisfy 
the detailed balance, the acceptance probability of the proposed move is modified. One 
needs to calculate the probability of the reverse move Bn —> A\. The super detailed 
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balance condition that ensures detailed balance, is satisfied by defining a set of k — 1 new 
trial moves Aj, from the proposed configuration Bn [19]. The set {A\,Aj} defines the 
reverse Rosenbluth weight as 
k 
W(o) = exp[-(3H(A1)] + J2^M-PH{Aj)}. (2.11) 
The normalized probability of selecting the reverse move is 
VT = exp[-0H{Ai)]/W(o). (2.12) 
The super detailed balance condition is written as 
n(Ai)T(Ai -* Bn)acc(A1 -> Bn) = n(Bn)T(Bn -» AJacciBn -» Ai), (2.13) 
where n(A) oc exp[—/3H(A)] is the limiting distribution that one wants to sample. 
The probability of accepting the proposed move is acc(Ai —• Bn). The forward transition 
probability is T(A —> Bn) is just the probability of selecting the configuration, p^P^, 
and the reverse transition probability is p^p6*1. The super detailed balance condition is 
given by 
19 
acc{A1 -> Bn) = n(Bn)p^pe0xt = W(n) 
acc(Bn-*Ax) ir(Ax)rf*ti* W{o)' 
The acceptance probability is chosen to be 
(2.14) 
acc{A1 -» Bn) = min ( 1, ^ j ) . (2.15) 
A value of k = 5 is used for the biased move. However, at low temperatures, mere 
biased Monte Carlo moves are unable to sample the rough figure of merit efficiently. 
For difficult structures (n > 9), sampling is improved dramatically by employing the 
method of parallel tempering. A temperature ladder is chosen that allows for a reasonable 
overlapping of energy histograms between the neighbouring temperatures. 
2.3 ZEFSAII results 
2.3.1 Data collection and Indexing 
Synchrotron X-ray powder diffraction data (Fig. 2.1) for as-made CLS-3 were col-
lected on the X16C beamline at Brookheaven National Laboratory in Debye-Scherrer 
20 
2e+05 
CLS-3 
Diffraction Pattern 
Figure 2.1 X-Ray diffraction pattern for CLS-3. 
21 
mode. The data sample were collected for the 'as made' material at ambient tempera-
ture using a step size of 0.005° from 3.5° to 50° 20 with a wavelength of A = 1.19958A. 
The diffraction pattern was indexed in a triclinic lattice with Pi symmetry using TREOR 
[20]. The cell parameters are given in Table 2.2. 
Table 2.2 Cell size from indexing of CLS-3. 
cell side 
a 
b 
c 
A 
7.508 
9.509 
15.652 
cell angles 
a 
P 
7 
o 
94.309 
109.699 
64.941 
The NMR studies of the sample showed 5 unique T atoms with two of the atoms 
having 3 unique T atoms (instead of the usual 4) in their first coordinate shells. There 
was a clear indication that the zeolite in question had a layered structure. 
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2.3.2 Preparation of the input files 
The data from diffraction experiment was modified into a suitable format before it was 
used as an input for the simulations. For given cell dimensions, symmetry operators, and 
X-ray wavelength ZEFSAII outputs all of the reflections along with their multiplicities. 
It assigns random intensities to these peaks. Some of the peaks that are too close to be 
resolved experimentally are grouped together into a single composite peak. The random 
intensities were replaced by the experimental intensities. In a composite peak, all other 
peaks except the last one were assigned a negative intensity. The sum of all the intensities 
in that group was then assigned to the last reflection in the group. Once all the composite 
peaks were identified, the intensities were normalized to 1000. Weights were assigned to 
the peaks according to their intensities as explained in Table 2.3. Larger peak indicates 
more uncertainty in intensity calculation. These peaks were assigned larger weights so 
as to count them less while comparing calculated and experimental patterns. 
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Table 2.3 Intensity dependent weights in ZEFSAII. 
Scaled intensity range 
0-100 
100-200 
200-300 
300-500 
>500 
Weight 
1 
2 
3 
4 
5 
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The initial fractional coordinates for the Si and O atoms were generated randomly. 
A density of 10 T atoms/1000 A3 was considered as suggested by chemical analysis of 
the ample. The presence of structure directing agent (SDA) and the low symmetry 
triclinic setting of the unit cell meant one had to account for the scattering density of 
the SDA. Chemical analysis of the material pointed towards 1 template molecule per 
unit cell. Therefore, one SDA molecule was included within the unit cell. The positional 
and rotational degrees of freedom of the SDA molecule entered the figure of merit only 
through the diffraction terms; energetic interactions between framework atoms and SDA 
were not considered. Fig. 2.2 shows the SDA molecule. Information about the detailed 
procedure for running ZEFSAII simulations could be found on Deem group's web page 
[21]. 
In order to determine temperatures for the parallel tempering, several short simula-
tions with different temperatures were run. Resulting energy histograms were visually 
inspected. The final temperatures were decided; based on the extent of the overlapping 
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Figure 2.2 Structure directing agent for CLS-3 synthesis. 
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between adjacent histograms. Table 2.4 lists the selected temperatures for the corre-
sponding replicas in parallel tampering simulations. 
Table 2.4 Temperatures used in parallel tempering. 
Replica 
1 
2 
3 
4 
5 
6 
Temperature 
6 
12 
22 
45 
130 
480 
In all, 25 runs were carried out for a given set of input files. Using different random 
numbers, the figure of merit was sampled in independent ensembles. The structures 
from the runs were scanned in order to collect those structures that had reasonably low 
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energies (< 1000 Kcal/mol), and had in their structure at the most two T atoms that 
were 3 coordinated. Fig. 2.3 shows the energy histogram for a representative run. The 
histograms overlap reasonably well indicating that the replicas were able to move freely 
across the temperature ladder. 
CLS-3 
1500 
1000 h 
c 
s o o 
500 1000 
energy (Kcal/mol) 
1500 2000 
Figure 2.3 Energy histograms from a representative parallel tempering run at different 
temperatures (ks = 1). 
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Scanning the results of all the simulations resulted in two structures being found in 
18 of the 25 runs. Out of the 18 runs, in 11 cases one of the two structures had the lowest 
energies for that simulation. The structures were closely related to each other. Solution 
1 had two T atoms that were 3-coordinated, whereas, solution 2 had all 5 T atoms that 
were 4-coordinated. The structures are composed of cages with 2 four-rings, and 4 five-
rings. These cages were connected together to form chains in the two directions within 
the layers. Fig. 2.4 and Fig. 2.5 represent the coordination sequence and structure for 
the two cases. Structure 2 can be obtained by adding two bonds along the a-axis in 
structure 1. 
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Figure 2.4 Structure and coordinate sequence for solution 1. 
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Figure 2.5 Structure and coordinate sequence for solution 2. 
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2.4 Structure Refinement 
Solution 1 obtained from ZEFSAII was further refined using the Rietveld refinement 
method [22]. The software GSAS/EXPGUI was used to carry out the refinement process. 
GSAS (General Structure Analysis System) [23] is a comprehensive set of tools to refine 
the structural models to both X-ray and neutron diffraction data. EXPGUI [24] is a 
graphical user interface (GUI) editor for GSAS experiment files and shell which allows 
all other GSAS programs to be executed with a GUI. In the following section, I explain 
the Rietveld method for structure refinement in brief. 
2.4.1 Rietveld Method 
A powder diffraction pattern of a crystalline material comprises of individual reflection 
profiles. Each profile has a peak position, peak height, breadth, tails that decay gradually 
from the peak position, and an integrated area proportional to the Bragg intensity, Ihku 
where hkl represent the miller indices. Analysis of the measurements of these peaks, 
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can reveal several aspects of the material's structure. In order to obtain such structural 
information from diffraction experiments, Rietveld proposed a method that uses a least 
squares approach to refine a theoretical line profile till it matches the experimentally-
measured profile. The method was first applied to neutron data, but was soon extended 
to X-ray diffraction data [25, 26]. Rietveld refinement is now commonly applied to both 
laboratory and synchrotron X-ray data [27]. 
For powder data obtained from a constant wavelength source, numerical intensity 
value, y,, is measured at each increment, i, in scattering angle 20. With a good starting 
point at hand, the objective is to obtain the best least-squares fit to all of the thousands 
of j/j's simultaneously. The refinement minimizes the residual, Sy. 
Sy = J2wi(yi-yCi)2 (2.16) 
where w; = 1/j/j, statistical weight, 
j/i = observed intensity at the ith. step, 
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yCi = calculated intensity at the zth step, 
and the sum is over all data points. 
In most cases, not all the peak profiles are resolved, but rather partially overlap one 
another. Normally, many Bragg reflections contribute to the intensity, y;, observed at any 
point, i, in the pattern. In order to determine the calculated intensities, yci, contributions 
from neighbouring Bragg reflections are taken into account along with the background: 
yci = s ^ LklFual^Oi - 26hkl)PhklA + yu (2.17) 
hkl 
where s is the scale factor, 
Lhki comprises of the Lorentz, polarization, and multiplicity factors, 
4> is the reflection profile function, 
Phki is the preferred orientation function, 
26i is the peak position 
29hki is the center of the peak 
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A is an absorption factor, 
Fhki is the structure factor for the hkl Bragg reflection, and 
yu is the background intensity at the ith step. 
Minimization procedures via Newton-Raphson with least squares lead to a set of 
normal equations that involve derivatives of all the calculated intensities with respect to 
each adjustable parameter. These equations are solved by inverting the normal matrix 
given by the following equation. 
o2 
Mjk = - ]T 2wt[(yi - ya)g^-} (2-18) 
Here the the parameters Xi, Xj represent the adjustable parameters. As the residual 
function is non-linear, an iterative procedure is required to find the solution. The shifts, 
Axk, are given as follows: 
**-£*# sir <2-19> 
An improved model is obtained by applying the shifts to the original parameters. 
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The procedure is then repeated until convergence to a minimum. Due to the non-linear 
relationship between the intensities and the adjustable variables, the starting point needs 
to be close to the correct model. Otherwise, the procedure will either diverge or lead to 
a false minimum. It is important to note that the Rietveld method is a structure refining 
technique, not a structure solution method, and needs a good starting point to achieve 
convergence. 
2.5 Rietveld refinement results 
The Rietveld refinement of the as-made CLS-3 from synchrotron X-ray diffraction 
data was performed using the space group Pi. The intense 001 peak was excluded from 
the refinement because of severe peak shape problems at low angles. During indexing of 
the powder data, three peaks were unaccounted for. These peaks were at 26 values of 
17.3°, 21.3°, and 23.0° respectively. These peaks were thought to be arising from a small 
zeolite beta impurity, and were consequently dropped from the refinement. 
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The selected structure from ZEFSAII runs was used as a starting point. Cerius 
package was used to insert oxygens and to severe the long Si-O-Si bonds between the 
layers and to terminate them with the silanol-siloxy pairs for the refinement. 
The pseudo-Voigt function of Thompson et. al. [28] and the asymmetry correction 
described by Finger et. al. [29] were used to model the peak profiles. The 'Chebyshev 
polynomial of the first kind' was used to model the background contribution. Atoms of 
the same type were grouped together and were constrained to have the same isotropic 
thermal displacement factors. Two different methods were employed for the treatment 
of the organic molecule during the refinement stage. 
2.5.1 Method of soft restraints 
Method of soft restraints treats the SDA as a flexible molecule. GSAS provides a set 
of stereo chemical restraints with an appropriate standard deviation assigned to each. A 
weight factor determines the extent of effect a restraint would have on the minimization 
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process. In the case of CLS-3, bond-length restraints were applied. Table 2.5 lists the 
restraints placed on different types of bonds involved, and their respective standard 
deviations. The O-Si-0 angles were restrained indirectly by restraining the Si-0 and 
0-0 distances. 
Table 2.5 Soft restraints. 
Bond type 
Si-0 
0-0 
C-C 
C=C 
C-N 
Restraint (A) 
1.60 
2.61 
1.54 
1.40 
1.47 
Standard deviation (A) 
0.03 
0.05 
0.03 
0.03 
0.05 
At the beginning of refinement the weights were set to a large value (250) to avoid 
diverging refinement. Table 6 provides the refined atomic position parameters for the 
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zeolite as well as for the organic template. Table 2.6 provides the average bond distances 
and the maximum and minimum values of the bond lengths for the different types of 
bonds. 
Table 2.6 Average bond lengths for the method of soft restraints. 
Bond type 
Si-0 
0 -0 
C-C 
C=C 
C-N 
Average bond distance (A) 
1.61 
2.61 
1.56 
1.42 
1.52 
Max (A) 
1.65 
2.69 
1.61 
1.44 
1.56 
Min (A) 
1.56 
2.51 
1.54 
1.41 
1.51 
After nearly 700 cycles, the refinement converged to a Rp value of 22.14% and a B^p 
value of 27.03%. The refinement results are summarized in Table 2.7. The structure at 
the end of refinement (with restraint weight = 250) is shown in Figure 2.6. 
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Figure 2.6 Framework and template structure after refinement for the soft restraints 
method. 
Table 2.7 Rietveld refinement results for soft restraints. 
space group 
a 
b 
c 
a 
P 
7 
wavelength 
profile range 
Rp 
•rtwp 
d 
T\ 
7.50A 
9.51A 
15.66A 
94.30° 
109.72° 
64.97° 
1.19958A 
7.05°-50.0° 
21.91% 
26.93% 
0.075 
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2.5.2 Organic molecule as a rigid body 
The second method treats the organic template as a rigid molecule. This is a much 
more involved process than that of soft restraints. It is especially useful when working 
with powder data. Treating the template as a rigid body avoids meaningless changes 
within the molecule. The molecule undergoes only translational or rotational changes. 
Theoretically, only 6 parameters are needed to handle the rigid body, 3 parameters to de-
fine the position (x, y, z) of the center, and 3 rotation parameters. GSAS, however, reads 
in 3 additional rotation parameters. Such treatment of the template saves computing 
time, and enables inclusion of light atoms (hydrogens) from the beginning. Overall, this 
method leads to a more stable refinement where the probability of divergence is reduced, 
and one is more likely to converge on to the correct structure [30]. 
In GSAS, the rigid body coordinates are given as Cartesian coordinates. For small 
molecules, the coordinates for rigid bodies are calculated from the knowledge of bond 
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lengths and bond angles [30, 31]. Bigger molecules are rather difficult, but if one knows an 
already existing structure, where the atomic coordinates are known, a shortcut could be 
applied [32]. A center is chosen for the rigid body. The center of gravity is a good choice. 
The respective coordinates of the center of gravity are subtracted from the respective 
coordinates of all other atoms (x coordinate of the center from x coordinate of an atom, 
and so on). These new coordinates are inserted under the option of rigid body in GSAS. 
The results of the refinement following inclusion of the SDA as a rigid body are 
tabulated in Table 2.8. After nearly 850 cycles, the refinement converged to a Rp value 
of 28.31% and a R^p value of 32.99%. The structure of the zeolite and the SDA template 
are shown in Figure 2.7. 
2.6 Discussion and Conclusions 
The Rietveld refinement tries to minimize the residual in equation 20 through adjust-
ments to the refinable parameters until the 'best fit' is obtained between the calculated 
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Figure 2.7 Framework and template structure after refinement for the rigid body method. 
Table 2.8 Rietveld refinement results for rigid body. 
space group 
a 
b 
c 
a 
P 
7 
wavelength 
profile range 
Rp 
•Kwp 
d 
Pi 
7.50A 
9.51A 
15.67A 
94.30° 
109.72° 
64.99° 
1.19958A 
7.05°-50.0° 
28.31% 
32.99% 
0.059 
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and the observed pattern. There are several criteria available to check the goodness of 
the 'best fit' obtained during the Rietveld refinement. A particular 'best fit' depends on 
the adequacy of the model, and on whether the procedure reached a global or a local 
(false) minimum. 
In literature, people often provide the R-pattern (Rp) and R-weighted pattern (ilwp) 
values to indicate the goodness of the fit obtained. For a correctly solved structure that 
is well refined, the R terms range from 5% — 15% [33, 34]. These values are defined as 
follows: 
= EJyi(°frg)-y»Mc)l ,2 2Q. 
o (Tn. wM°bs) - yi(caic)]2\1/2 
^
={ ZMvi(obs)y ) (2-21) 
The R-values have in their numerator, the residual that is being minimized, hence 
from mathematical point of view, these values are important, and best reflect progress 
of the refinement. Another statistic that is often quoted is the Durbin-Watson statistic, 
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d. It is defined as 
Ef=iAy? 
where Ay* = yi(obs) - y. 
It reveals the serial correlation between the successive y* values. The ideal value 
for this statistic is 2.00 [27]. In case that the calculated and observed profiles do not 
match well due to reasons of shape and/or area, there is a strong serial correlation of the 
residuals. The D-W d in both, soft restraints and rigid body cases are far from 2.00. 
Although numerical criteria are important, these values could be misleading at times. 
The difference plot, along with the observed and calculated peak profiles provides a better 
indication of the direction in which the refinement is heading. Errors in such parameters 
as scale factor, lattice parameters, zero offset, and structure are obvious in the plots, 
but not necessarily in the R values. These plots for both, soft restraints and rigid body 
treatment of SDA can be seen in Fig. 2.8 and Fig. 2.9 respectively. 
47 
1 2 5 2 - R E S T R A I N T S cycle 707 Hist 1 
"——bck 
- — C a l 
X Ob 
—
—
 difl 
m^rTff^^ 
10 30 
Figure 2.8 Experimental, calculated and difference plots for diffraction data for the soft 
restraints method. Peaks at 20 values of 17.3°, 21.3°, and 23.0° that could not be indexed were 
omitted from the refinement. 
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RIQID.BODY cycle 858 Hist 1 
10 40 
Figure 2.9 Experimental, calculated and difference plots for diffraction data for the rigid 
body method. Peaks at 26 values of 17.3°, 21.3°, and 23.0° that could not be indexed were 
omitted from the refinement. 
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Rietveld refinement of the structure obtained from ZEFSAII led to Rp and R^p values 
between 25 % - 30 % range. The background function looks reasonably well fitted. 
However, the difference plots show a disagreement between the observed and fitted peak 
profiles. Few of the observed peaks are missing from the calculated profile, indicating 
a possible problem with unit cell size or space group. However, since the indexing was 
able to account for all but three peaks (that were thought to be due to a zeolite beta 
impurity), it is more likely that the starting point of the refinement is not close enough 
to the correct solution. The non-linear refinement method is unable to overcome this 
handicap, and ends up settling into what looks like a false minima. This fact is reflected 
in the less than ideal D-W d values for both the cases. 
It is clear from Fig. 6 that in spite of the use of the restraints with larger weights, 
the structure of the SDA does not look chemically sensible. Clearly, the atoms in the 
template are too close to each other. The rigid body treatment fared better in this sense, 
however, refinement with that procedure led to higher R^p and R^ values, and a more 
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pronounced difference plot. It is clear that the soft restraints method is able to achieve 
better statistics through unphysical movement of the atoms involved. Further reduction 
in the weights led to complete condensation of the template atoms (not shown). Rigid 
body method on the other hand is better in keeping the geometry intact of larger template 
molecules. 
Failure of the refinement method thus implies that the starting structure is not close 
enough to the correct one. There are three possible reasons. The CLS-3 has an open 
framework structure, in that there are 2 atoms that are 3-coordinated. ZEFSAII favours 
4-coordinated T atoms. For 3-coordinated structures, there are many more possible 
structures. The second factor is the presence of the organic template. In its presence, 
in the regions that are occupied by the non-framework atoms, the #PXD term tends 
to favour nonzero scattering density. This leads to ambiguity in the diffraction term. 
Due to these two factors the method ends up finding several incorrect structures that 
could still be feasible from a geometrical point of view. A diffraction pattern obtained 
51 
from a calcined zeolite sample, where the template molecule has been removed, would 
be an ideal starting point for ZEFSAII. However, layered materials are usually unable 
to remain stable after calcination. The layers are unable to connect with one another to 
form an intact zeolite structure. The opposing layers do not line up well enough for the 
layers to neatly condense. The efforts to calcine the CLS-3 sample failed as the material 
became completely amorphous. The third difficulty is that the sample may be disordered 
or multiple phase. For example, the peaks at 29 values of 17.3°, 21.3° and 23.0° in the 
PXD indicate some potential presence of zeolite beta. 
In conclusion, the solution to the layered material CLS-3 has yet proved to be elusive 
to ZEFSAII. More efforts on both the experimental and computational level could yet 
lead to the correct solution that could then be verified through the Rietveld refinement. 
The existence of another phase also needs to be investigated since the indexing fails to 
account for 3 peaks. 
Chapter 3 
Determination of dielectric constant and elastic 
modulus for single crystal ZSM-5 
3.1 Low dielectric constant (low-fc) zeolite films 
This project was a collaborative effort with Dr. Yushan Yan, University of California 
at Riverside (UCR), and with Dr. Wataru Shinoda, National Institute of Advanced 
Industrial Science and Technology, Japan. 
A distinct feature of zeolites is the uniform nanometer-scale pore structure (diameter 3 
- 10 A) of these materials. This feature has been exploited in industry with great success. 
Zeolites have been used as catalysts and separation media for decades. Micro-meter scale 
zeolite crystals are usually combined with a binder in order to form millimeter-scale 
granules or pellets in these applications. Recently, zeolite nano-particles in a thin film 
configuration have been proposed, studied, and shown to hold promise for a plethora of 
new applications [35]. These applications include low dielectric constant films critical to 
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the speed of future generation computer chips among others. 
Since the inception of the integrated circuit (IC) in 1961, the evolution of the IC 
industry has taken place at a remarkable speed resulting in the manufacturing of fast 
and affordable computers. The ability to increase the number of transistors on a single 
chip through miniaturization has been at the root of this speedy evolution. In order to 
continually increase the number of transistors per chip, a low-A; material is needed for 
effective insulation of the metal wires connecting the transistors that will minimize the 
crosstalk noise, power dissipation, and RC delay [36, 37]. The International Semicon-
ductor Technology road map (www.sematech.org) portends the need of a low-k material 
with a k value of 1.6 by 2010. No manufacturing processes that give such a low value 
are known at present. A number of candidates have been looked into as potential low-A; 
materials. For dielectric films, nonporous silica (k = 4) has been the preferred material 
since the beginning of the semiconductor industry. It has been suggested to increase the 
porosity of silica to lower its k value, since k^ = 1. Higher porosity, however, weakens 
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the film and renders it fragile during the chemical and mechanical processing. A bal-
ance between low dielectric constant and high mechanical strength is crucial to the use 
of any material as a thin film substrate for integrated circuits. There are three major 
classes of porous silica, namely sol-gel silica, surfactant-templated mesoporous silica and 
pure-silica-zeolite (PSZ) that are being looked into for possible uses as thin dielectric 
films. 
With the use of super critical drying in aero-gel creation, sol-gel silica can be designed 
to have very high porosity resulting into a very low k value (~ 1.2) [38, 39, 40]. However, 
there are several practical problems. The high porosity in sol-gel silica results into low 
mechanical strength and low thermal conductivity. The threshold for elastic modulus as 
established by the semiconductor industry for the low-k materials is 6 GPa. The drying 
induced shrinkage is another drawback, so is the wide-pore size distribution which can 
cause electric breakdown. Finally, since sol-gel silica is hydrophilic, it tends to absorb 
water. Due to its high dielectric constant (fc=80-90) even minor adsorption of water can 
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drastically increase the A; value. 
Surfactant-templated mesoporous silica has a pore size distribution that is narrow 
compared to sol-gel silica resulting in a better mechanical strength. However, due to its 
amorphous nature, mesoporous silica still suffers from low mechanical strength and high 
hydrophobicity. 
Pure silica zeolites (PSZs) on the other hand posses high mechanical strength and 
heat conductivity because of their dense crystalline structure. They have small pores (< 
1 nm) and a very narrow pore size distribution, thus minimizing the electric breakdown 
problem. Also, PSZs are hydrophobic, resulting in reduced water adsorption. Due to 
these qualities, researchers at UCR have studied PSZ low-fc films for past few years [41]. 
The efforts have been focused on MFI (ZSM-5). Not only because it is highly hydrophobic 
and has high porosity (~ 33%), but also because there are several synthesis procedures 
available for MFI. 
For low-A; film applications, two of the most important properties are dielectric con-
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stant and elastic modulus. Calculation of these and other mechanical properties for 
two systems, ZSM-5 and ZSM-5 with an embedded tetrapropylammonium (TPA) ion, is 
described in this chapter. 
3.1.1 Framework structure of ZSM-5 and location of the tetrapropylammo-
nium ion 
The initial structure for ZSM-5 and TPA system was taken from Koningsveld et 
al. [1]. The structure was solved using X-ray diffraction method on a single crystal of 
Siii.96Al0.04O24.0.5NCi2H28OH. All twelve SiC-4 groups in the solved structure resemble 
the ideal tetrahedral geometry. The average Si-0 distance in each tetrahedron is 1.587 
A, and the average O-Si-0 angle is 109.47°. ZSM-5 has ten-membered rings that define 
a three dimensional channel system. There are two types of channels, straight, and si-
nusoidal. The straight channels are along [010] and sinusoidal channels are parallel to 
[100]. The structure was refined in Pnma symmetry (8 symmetry operators). The frame-
work symmetry deviation was found to be too small to refine in a lower-symmetry group 
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Pn2ia. The dimensions for the orthorhombic unit cell were reported as a = 20.022(2) A, 
b = 19.899(2) A, and c = 13.383(1) A. 
The TPA+ ion populates the intersection of the straight and sinusoidal channels in 
two different orientations in a ratio of 3:2. The positional parameters for the framework 
are given in Table 3.1, and those for one of the two orientations of the template are given 
in Table 3.2. 
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3.2 General Utility Lattice Program (GULP) 
The dielectric constant for ZSM-5 and ZSM-5+TPA systems was calculated using 
GULP [42]. GULP is designed to perform a variety of simulations for solid systems. In 
GULP, the internal energy is assumed to be an expansion in terms of increasingly higher 
order interactions between the total number of atoms, N: 
N
 1 N N 1 N N N 
i = l i = l j=l i—1 j=\ fc=l 
where, the first term represents the self energies, the second the pairwise energies, and 
so on. It is known however, that the contribution from higher order terms progressively 
diminishes for most systems. Consequently, GULP neglects terms beyond four body 
interactions. A certain degree of parametrization of the remaining terms is introduced 
in the force fields to compensate for the omitted terms. The following potentials were 
included for the calculation of dielectric constants: 
1. Coulomb interaction - Coulomb interaction is a dominant term in systems with 
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ionic materials. It's given by Coulomb's law; 
rCoulomb _ QiQj 
where, qi: q^ are the partial charges on the atoms, e0 is the permittivity of the 
medium, and r^ is the distance between the two atoms. Since the term is given by 
a conditionally convergent series, it is a complicated term to evaluate for periodic 
systems. The method of Ewald [43] was employed to yield a convergent series with 
a well-defined limit. 
2. Two-body short-range interactions - The interactions between atoms when they are 
bonded, or between ions when they are in the immediate coordination shells, are 
included under these terms. The attractive dispersion term is combined with the 
exponentially varying repulsive term as follows: 
^Buckingham
 = ^ e x p / ' _ ^ N \ _ ^ ^ 
V P J 'ij 
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For covalently bonded atoms, a harmonic potential is used of the form 
^ H a n n o n i c = l f c a ( r _ r o ) 2 _ ( 3 4 ) 
Here, fc2 is the spring constant, and r0 is the expected distance between the 
covalently-bonded atoms. 
3. Three-body interactions - From a covalent perspective, the three-body potential 
represents the repulsion between bond pairs. It penalizes deviation from the ex-
pected angle for the coordination sequence, and it is given as 
Uijk = \k2{e-eQf+l-kz{e-eQf + ^h{e-e0)\ (3.5) 
Here, 90 represents the planar angle between the three atoms, and k2, k3, and k$ 
represent the force constants. 
4. Four-body interactions - This term describes energy associated with twisting the 
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torsional angles, and have the following form: 
Uijki = k4[l + mcos(n<f> - <f>0)]. (3.6) 
5. Polarizability - The dipole moment of an atom cannot be assumed to be fixed. 
It changes both in magnitude and direction according to the polarizability of the 
species. Polarizability is treated in the simulations via the ion-pair shell model [44]. 
The model separates an ion into two parts, namely a core, which represents the 
nucleus and inner electrons of the ion and has the atom mass associated with it, 
and a shell that mimics the valence electrons. The core and shell are Coulombically 
screened from each other, but coupled through a harmonic spring of force constant 
K^. The in vacuo polarizability of the ion is given by 
(3.7) 
where qs is the shell charge. The short range forces by convention act on the shell, 
whereas the Coulomb potential acts on both. The short range forces change the 
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spring constant between the shell and the core, thus changing the polarizability, 
which now depends on the environment. 
3.3 Calculation of the dielectric constant 
Depending on the frequency of the applied electromagnetic field, the actual value of 
the dielectric constant, k, varies. It is common practice to quote two extreme values of 
k, namely the static and high frequency dielectric constants. In the static limit both 
the electronic and nuclear degrees of freedom respond to the applied electric field, thus 
providing screening. In the high frequency limit, however, only the electrons respond to 
the perturbation. 
The 3 x 3 tensor of static dielectric constant is calculated from Da/3, the Cartesian 
second derivative matrix of all particles, and the vector, q, which contains the charges on 
all particles. 
Afjr 
£p = Safi +-TriqDjiq) (3.8) 
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The high frequency dielectric constant is calculated with the same formula; the only-
change being that Dap now only includes the Cartesian components for all shells present 
in the model. 
The dielectric constant at high frequency has a relatively direct correlation to the shell 
model as the second derivatives matrix, Dap, includes only the Cartesian components of 
the shells that are present within the model. Also, since the dielectric constant tensor 
depends on the inverse of Dap, it shares several characteristics of the Hessian matrix, 
and hence is a sensitive indicator of the goodness of the potential model. 
3.3.1 Results 
Three different systems were simulated using GULP. 
1. ZSM-5: After the application of symmetry operators, the unit cell consisted of 288 
atoms (96 silicon and 192 oxygen). 
2. ZSM - 5 - TPAx: This system had a total of 340 atoms that included 4 TPA 
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molecules. The subscript refers to one of the two orientations of the TPA molecule 
that was found in the Koningsveld paper [1]. 
3. ZSM — 5 — TPA2: The second orientation of the TPA molecule was included in 
this simulation. 
Simulations were carried out at constant pressure i.e. the unit cells were allowed to 
change shape and size. The force field parameters were taken from the force field due 
to Jackson and Catlow [45]. Cut and shift approach was used in order to make all the 
potentials calculable. Once the energy was defined, the structure was optimized using 
the Newton-Raphson procedure. Optimization was achieved in each of the three cases. 
Once optimization is achieved, a wide range of physical properties could be calculated 
based on the curvature of the energy surface about the minimum. The results for the 
dielectric constant are given in the following tables, 3.3, 3.4, and 3.5. The framework 
structure of ZSM - 5 - TPAX is shown in Fig. 3.1. 
Table 3.3 ZSM-5 : Dielectric tensor constants 
Static dielectric tensor 
X 
y 
z 
X 
3.45630 
0.00000 
0.00000 
y 
0.00000 
3.40811 
0.00002 
z 
0.00000 
0.00002 
3.29604 
High frequency dielectric tensor 
X 
y 
z 
X 
1.70855 
0.00000 
0.00000 
y 
0.00000 
1.70770 
0.00000 
z 
0.00000 
0.00000 
1.69515 
Table 3.4 ZSM - 5 - TPAi : Dielectric tensor constants 
Static dielectric tensor 
X 
y 
z 
X 
3.51045 
0.00026 
-0.00042 
y 
0.00026 
3.43768 
-0.00197 
z 
-0.00042 
-0.00197 
3.33034 
High frequency dielectric tensor 
X 
y 
z 
X 
1.71216 
0.00000 
0.00000 
y 
0.00000 
1.71125 
-0.00005 
z 
0.00000 
-0.00005 
1.69864 
68 
i * • ; - * * 
Figure 3.1 ZSM — 5 — TPAi framework structure, looking down the straight channel (b-
axis). 
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Table 3.5 ZSM - 5 - TPA2 : Dielectric tensor constants 
Static dielectric tensor 
X 
y 
z 
X 
3.70680 
-0.00075 
-0.00228 
y 
-0.00075 
3.44273 
-0.00001 
z 
-0.00228 
-0.00001 
3.41553 
High frequency dielectric tensor 
X 
y 
z 
X 
1.71551 
0.00000 
-0.00001 
y 
0.00000 
1.71532 
0.00000 
z 
-0.00001 
0.00000 
1.70151 
Due to limitations in experimental measurements it is sometimes difficult to make 
the measurements of the dielectric constant in thin film zeolites [46]. However, it will be 
interesting to compare the calculated values with the experimental ones as they become 
available from the researchers at UCR. The important thing to note in these simulations 
was the effect the organic template molecule (TPA) has on the dielectric constant of ZSM-
5. From the tables, the high-frequency dielectric tensors for ZSM-5 and ZSM-5+TPA 
systems are within 1% of each other. The low-frequency dielectric tensors for the two 
systems vary up to 7%. Also, the change of orientation of the template seems to have 
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a pronounced effect on low-frequency dielectric tensors; with values changing up to 5% 
between the two orientations. 
3.4 Calculation of the elastic constants 
The following discussion is taken from an article due to Sprik et al. [47]. 
Calculation of the elastic constants from MD simulations relies on evaluation of strain 
fluctuations in the NpH ensemble. These fluctuations are used to determine the adiabatic 
compliances, which in turn yield the elastic constants [48]. During the MD simulation, 
a system of particles under external stress is simulated. The time dependence of three 
basic vectors a, b, and c that specify the edges of the MD cell is recorded [48, 49]. The 
vectors are saved in a 3 x 3 matrix h. Parrinello-Rahman Lagrangian gives the time 
evolution of the 3N + 9 coordinates {v, h} as 
1 1 
L
 = 2 5 1 m i ^ ^i-V + -WTr{hTh) + Vd, (3.9) 
where F = hs, G_ = f^h, and h? is the transpose of h. W is the mass associated with 
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the coordinates h\^. V represents the potential energy that determines the interaction 
between the particles. Vei is the elastic energy of the system, and is a function of the 
applied stress S and the strain e. Under the conditions of zero external stress, Vei is given 
as 
Vei = noTr(S_e), (3.10) 
where QQ = ||^Q|| represents the unstrained volume. A closed set of dynamical equa-
tions are derived from the Lagrangian (Eq. 1). The strain tensor e is expressed in terms 
of the 3N -I- 9 coordinates as 
£W = ^ fco _ 1 G(*)^ 1 - l ] - (3-11) 
Here, G{t) represents the instantaneous value of the metric tensor in the strained 
state, and h0 is the average matrix defining the simulation cell in the reference state. 
The strain in Eq. 3 describes a homogeneous deformation that fluctuates in time. The 
dynamics generated by the Lagrangian with the given definition of the elastic energy 
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conserves the enthalpy H. Therefore, time averages over an MD trajectory correspond 
to the expectation values in the HpN ensemble. The equilibrium fluctuations in this 
ensemble are related to the adiabatic compliances, T^kl, according to Parrinello and 
Rahman [48, 49]. 
<AeijAew> w = ^r°jkl. (3.12) 
Eq. 4 enables the determination of the elastic compliances from the time averaged 
fluctuations of the strain (Eq. 3) in the reference state. Due to the permutation symmetry 
for the Cartesian indices, the 9 x 9 matrix Tfjkl is singular. In order to invert the matrix, 
it is reduced to a non singular (and now non-symmetric) 6 x 6 matrix T^. The Voigt 
convention [50] relates the two matrices as 
r ^ = r-,w> k = l(a<3) (3.13) 
= 2Tsijkh k^l(a>3). (3.14) 
The inverse of T* is also a 6 x 6 non-symmetric matrix. The symmetric 9 x 9 matrix 
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of the elastic constants in the Cartesian representation is obtained from this matrix. 
3.4.1 MPDyn 
One of the approaches in calculation of the elastic constants of solids involves molec-
ular dynamics (MD) under the NtH ensemble [49, 51, 52]. Under this scheme, the 
simulation cell containing N atoms changes its shape conforming to the external stress 
t and enthalpy H. However, such MD simulations are time consuming [53, 47]. Even 
under the zero-stress condition, millions of sampling steps are required during the cal-
culation of the elastic constants in order to get satisfactorily converged results. As an 
alternative, Shinoda and co-workers proposed an algorithm in the NtT ensemble [54]. 
Non-Hamiltonian equations of motion were used to generate the NtT ensemble. The 
equations were then solved using the time-reversible RESPA algorithm [53, 47]. Three 
types of thermostats could be used to control the system temperature, Nose-Hoover [55], 
Nose-Hoover chain [56], and massive Nose-Hoover chain[56]. Of the three methods, the 
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method of massive Nose-Hoover chain was found to be the most efficient [54], and hence 
used in the current simulations. The algorithm was incorporated in MPDyn, a suite of 
programs for molecular simulations [57]. Calculation of the elastic constants form the 
ZSM-5 and ZSM-5+TPA systems were carried out using the MPDyn program. 
Force field 
The potentials of the force field used in the present calculations for the zeolite struc-
ture were taken from the force field due to Burchart and co-workers [58]. This force field 
has been used in simulations to reproduce geometry, heats of formation, and the vibra-
tional frequencies of several zeolites reasonably well [58]. The bonding and non-bonding 
interactions of the TPA ions, and the interaction of the TPA ions with the oxygen of the 
zeolite framework were treated using the potential parameters of Oie et al [59]. Partial 
charges on the TPA atoms were taken from [60]. The interaction of the framework Si 
atoms and the TPA ions was considered entirely Coulombic. There is no comprehensive 
75 
set of parameters used for the molecule/zeolite interactions. However, the parameters 
due to Oie et al. have been used in literature to model interaction between ZSM-5 and 
TPA ions [60, 61] with success. The force field consists of the following terms: 
£totai = Kb(b - b0)2 + K0{6 - 90f + K+{1 + cos(n<£ - S)) + A;exp(flyry) - - # + j ^ ~ -
rij 4nerij 
(3.15) 
Here, the first term is a bond-stretching potential with Kb as the force constant and 
b, and 6Q as the actual and expected bond lengths respectively. The second term is 
the angle-bending term with KQ as the force constant, and 9 and 6>o as the actual and 
expected angle values. The torsion angle term and the non-bonded interactions are in 
form similar to those described under for the GULP simulation package. 
Simulation details 
The Ewald method was used to calculate the Coulombic interactions. The cut-off 
distance of 15 A was used. With the assumed Pnma symmetry (8 symmetry operators) 
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each unit cell of ZSM-5+TPA system has 4 molecules of TPA. Since the cut-off distance 
in a simulation needs to be greater than the half-box length during the simulation, a super 
cell of 2 x 2 x 3 dimensions with respect to the unit cell of ZSM-5 was generated to obtain 
a simulation box of 40.04 A x 39.78 A x 40.149 A. Consequently, the ZSM-5 system 
had 3456 atoms whereas the ZSM-5+TPA system had 5424 atoms in a three-dimensional 
periodic boundary box. During the MD simulations, variable size time-step was used 
with the smallest being 2 fs, and fluctuation times of the barostat and thermostats were 
set at 2 ps and 0.5 ps, respectively. MD simulation for ZSM-5 was run for 2.75 ns. MD 
simulation for ZSM-5-TPA system was carried out for 1.5 ns. The first 0.5 million steps 
steps were treated as the equilibration period, while the remaining 1.5 million steps were 
used for calculating averages. The cell parameters were stored every 10 steps. 
3.4.2 Results 
The energy conservation plot for the MD simulation of ZSM-5 is shown in Fig. 3.2. 
Energy conservation in MD 
ZSM-5 (2.75 ns) 
1 1 1 1 -i 1 1 1 - i 1 
-le+05 
I 
^ -2e+05 
a -3e+05 
-4e+05h 
-5e+05 
— Potential energy 
— Kinetic energy 
-— Total energy 
50000 le-f05 1.5e+05 
MD steps (x 0.1) 
2e+05 2.5e+05 
Figure 3.2 Energy conservation during MD simulation of ZSM-5. 
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The MD simulations gave rapid convergence of the cell length. Table 3.6 lists each 
component of the MD cell length averaged over the simulation period along with the 
statistical errors. Block averages, with each block consisting of 2.75 x 103 (ZSM-5), and 
1.5 x 103 (ZSM-5-TPA) MD time steps were used to calculate the statistical errors. The 
dielectric constant was calculated for the two simulations and are shown in Fig. 3.3 and 
3.4 . 
Table 3.6 Averaged cell length and its statistical error under zero external pressure. 
System 
ZSM-5 
ZSM-5-TPA 
2o(A) 
40.50435 ± 0.0098 
40.54238 ± 0.0460 
26(A) 
40.13439 ± 0.0048 
40.48785 ± 0.0244 
3c (A) 
39.28555 ± 0.0076 
41.00933 ± 0.0426 
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Elastic modulus (ZSM-5) 
MD (2.75 ns) 
2 3 
Number of blocks 
Figure 3.3 Elastic modulus (ZSM-5). Values are block averages with each block consisting 
of 5 x 104 steps. 
Elastic modulus (ZSM-5-TPA) 
MD (1.5 ns) 
2 3 
Number of blocks 
Figure 3.4 Elastic modulus (ZSM - 5 - TPAi). Values are block averages with each block 
consisting of 2.5 x 104 steps. 
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3.4.3 Discussion and Conclusion 
Experimental studies to determine mechanical properties of zeolite single crystals 
have been limited. One early study that investigated MFI single crystals with an in-
house micromechanical tester reported a low value of elastic modulus (~ 4 GPa) [62]. 
During the test the entire crystal was compressed in the tester. This might have amplified 
the effects of crystal-defects on the observed elastic modulus values. More recently Yan 
et al. reported a value of ~ 54 GPa using nano-indentation [46]. The in situ MFI film 
has been reported to have an elastic modulus between 30-40 GPa as calculated by nano-
indentation [63]. The method of nano-indentation does not compress the entire crystal 
at once. Rather it takes measurements at different locations on the crystal surface, thus 
reducing the effect of crystal defects on the measured values. As seen from Fig. 3.2 the 
value from the simulation lies between the reported values for ZSM-5 single crystal. A 
value of ~ 50 GPa has been reported for the elastic modulus of ZSM-5 single crystal by 
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Yan and co-workers [46]. The difference could be traced to the use of different force fields 
(BKS force field [64] for Yan et al.) in the two simulations. Comparison could be made 
with the experimental value between the ZSM-5-TPA system once they are available. So 
far attempts to prepare large single crystal without template by calcination have proved 
to be unsuccessful due to cracking related problems. From the simulation results, it is 
apparent that inclusion of the template increases the elastic modulus of the system by 
more than 30%, at the same time keeping the dielectric constant (at low frequencies) 
nearly unchanged. 
These computed values of dielectric constant and elastic modulus for ZSM-5 and 
ZSM-5-TPA systems indicate that these pure silica zeolites are able to achieve low k 
values while at the same time maintaining a high mechanical strength as indicated by 
their elastic modulus (> 6 GPa). This result is encouraging as it paves way for further 
research in the subject of PSZ films being used as a possible substrate for building 
integrated circuits. 
Chapter 4 
Comparison of Monte Carlo methods for simulation 
of cyclic peptides 
4.1 Introduction 
The free energy landscapes of biological molecules are complex, in that the conforma-
tions characteristic of room or body temperatures are separated by high energy barriers. 
Standard simulation methods such as Metropolis Monte Carlo (MC) and conventional 
molecular dynamics (MD) fail to sample these conformations from the correct Boltz-
mann distribution. The problem is particularly acute in the case of constrained peptides. 
High temperature [65] or potential scaled [66] molecular dynamics have been shown to 
cross these barriers, but these methods sample from a distribution that is not the one 
of interest. Frenkel and Smit [67] and de Pablo [68] developed a configurational bias 
Monte Carlo (CBMC) method that uses local information to propose new moves. This 
method has been successful in sampling the complex energy landscapes from the correct 
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Boltzmann distribution. It has been applied to the study of long chain molecules [69], 
such as long chain alkanes [70, 71], and to the study of hydrocarbon conformations in 
zeolite channels [72]. Based on a method for the alkane chains [73], Deem and co-workers 
developed a generalized concerted rotation scheme to study both linear and cyclic pep-
tides [74]. Especially for constrained molecules, the ability to change local topology up 
to two to three amino acids per move meant that even without the knowledge of the 
location of the conformations viz a viz energy barriers, CBMC proved to be considerably 
more efficient than the Metropolis scheme. In biological molecules effective equilibration 
of bulky side-chains is yet another challenge. A rebridging scheme [75], inspired by a 
method for polymers [76, 77, 78] has helped make further gains in terms of efficiency of 
the simulations. 
For more complex cyclic peptides, the CBMC method is combined with the method 
of parallel tempering [79]. A rigorous Monte Carlo method, parallel tempering was first 
proposed to study glassy systems, and has since been successfully used to study such 
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systems as spin glasses [80, 81], self-avoiding random walks [82], lattice QCD [83], linear 
peptides [84], and crystal structure determination [85]. 
Monte Carlo methods allow unphysical moves that help systems under study to escape 
local energy minima. For constrained geometries though these local moves may still 
fail to achieve equilibrium in a feasible amount of computational time, rendering the 
simulations unergodic for all practical purposes. Molecular dynamics on the other hand 
though deterministic, brings about change on a global scale throughout the system, 
imparting a breathing motion that could prove helpful for escaping the valleys in the 
energy landscape. Hybrid Monte Carlo method tries to combine the benefits of both 
MC and MD moves. The method was originally developed by Duane et al. in quantum 
chromodynamics [86]. Researchers have since used it to study condensed-matter systems 
[87], dense polymer chains [88, 89], and crystal structures [90]. 
Depending on the system under study and the goal of a particular simulation, one 
combination of these methods could prove more useful than another. In this chapter 
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results from four different combinations of simulation methods in the NVT ensemble on 
four different cyclic peptides are compared. Parallel tempering method was used in all 
four cases to speed up equilibration. These combinations are as follows: 
1. Molecular dynamics (MD) 
2. Molecular dynamics + configurational bias-regrowth-rebridging (MD+CBMC+RG+RB) 
3. Hybrid Monte Carlo (HMC) 
4. Hybrid Monte Carlo + configurational bias-regrowth-rebridging (HMC+CBMC+RG+RB) 
One of the aims of the study was to ascertain the consistency of the results from all 
the methods for a particular peptide. The methods could then be used to study the more 
complex cyclic peptides with disulfide bridges in future. The next section describes these 
methods. 
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4.2 Simulation Methods 
An all atom force field, Amber-94 [91] was used to model the peptides. The force 
field was developed for simulation of nucleic acids and proteins. Water is treated in an 
implicit manner with a dielectric constant. The energies were matched against those 
obtained from the TINKER [92] suite of programs for tri-peptides of each amino acid to 
confirm the veracity of the implementation. 
4.2.1 Configurational bias Monte Carlo method 
The CBMC method is based on the assumption that at room or body temperatures 
it is reasonable to consider the intramolecular potential energy to be composed of only 
torsional and non-bonded terms. The bond lengths and bond angles could be fixed at 
their equilibrium values, and only the torsional degrees of freedom could be sampled. 
This approach reduces the total degrees of freedom available to the system from 37V to 
•^ torsion, where N is the total number of atoms in the system, and ATtorsion is the total 
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number of torsion angles. This coarse-grain restriction in mapping the phase space is 
easily relaxed during the MD and HMC moves. 
With the above assumption, the CBMC move assumes a molecule to be comprised 
of a set of 'rigid units.' A rigid unit consists of a set of atoms that form a rigid body. 
The relative distance between any pair of atoms within a rigid unit is constant. Adjacent 
rigid units are connected by a single sigma bond. Rotation is allowed only around the 
sigma bond. 
The following discussion describing the CBMC moves is taken from [74]. There are 
two types of atoms in a peptide, backbone atoms and side chain atoms. Consequently, 
there are two types of CBMC moves. 
Type I moves change the positions of side chain atoms alone. It begins by identifying 
the side chain that it then regrows. The M rigid units involved are removed and then 
added one by one. The unit closest to the backbone is the first to be regrown. Each 
addition of the rigid unit is accompanied by the following four actions. 
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1. k different values of torsion angle fcj that connects rigid unit i to the previous rigid 
unit are generated with probability 
pjnt(^)ocexp[-/3ulnt(0u)]- (4-1) 
Here, (3 = \/k^T is the inverse temperature, and t4nt(0ij) is the part of internal 
energy. It couples unit % to the rest of the molecule, excluding units i + 1 to M. 
Partitioning of the energy into internal and external parts is arbitrary, and in this 
case u-nt is assumed to be zero. 
2. Of the generated values, one is picked with probability 
#*(*«) = exp[-/3ur(^)]/wex t(i), (4.2) 
where 
k 
U ;- t(0 = ^ e x p [ - / 3 u r t ( ^ ) ] . (4.3) 
i=i 
The term uf^&j) is the part of external energy that couples unit i with the rest 
of the molecule, excluding units i + 1 to M. 
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3. The first two steps are repeated until all the M units are regrown. 
4. The Rosenbluth weight is calculated as 
M 
W{n) = ~[[wext(i). (4.4) 
i=l 
It is used to account for the bias introduced in the move and the attempted move 
is accepted with a probability 
acc(o-+n) = min[l,W(n)/W(o)]. (4.5) 
The term W^ is the Roesenbluth weight for the reverse move. It is calculated as per 
steps 2 to 4, but one of the k orientations is the original geometry for each unit. 
Type II move changes the positions of backbone atoms, rigidly rotating the attached 
side chains. It is applied only to a linear peptide case, and is very similar to a type I 
move. 
For any Monte Carlo scheme to properly sample the Boltzmann probability distri-
bution, detailed balance needs to be satisfied. That the CBMC moves described above 
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Figure 4.1 Analytical Rebridging [75] 
satisfy the detailed balance is proved in [73, 93]. These moves have been proved to be 
especially effective while sampling cyclic peptides [94]. 
4.2.2 Analytical Rebridging 
The analytical rebridging scheme [75] causes a local conformational change within the 
molecule, and leaves the rest of the molecule fixed. It is used to equilibrate backbone 
atoms of a cyclic peptide. Consider a segment of peptide backbone shown in figure 4.1. 
The angles <po and fa are rotated, causing the rigid units between 0 and 6 to change. 
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The two rotations break the connectivity of the molecule. The task is to find analytical 
solutions to the geometrical problem of reconnection of the backbone units. It involves 
the reduction of twenty linear equations to an 8 x 8 determinant equation of one torsional 
angle. The determinant equation is equivalent to a polynomial of degree sixteen, limiting 
the maximum number of new geometrical solutions to sixteen. The determinant equation 
is further reformulated as an eigen value problem and solved using the QR algorithm [95]. 
In order to incorporate the method in MC simulations, a Jacobian factor necessary to 
satisfy detailed balance is included. The Jacobian accounts for the correction to the 
nonuniform distribution generated by rebridging moves. The rebridging move makes 
a fairly dramatic change in the backbone positions. This makes the move effective in 
equilibrating complex peptides. 
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4.2.3 Parallel Tempering 
For cyclic peptides, biased rebridging Monte Carlo is not optimally efficient. To over-
come the remaining barriers to effective sampling, parallel tempering move is used. In 
parallel tempering, an ensemble with n identical systems is considered. Each system is 
equilibrated at a distinct temperature T^i — 1, ..,n. In addition to the biased rebridg-
ing moves, swapping moves are proposed that exchange the configurations between two 
systems i and j = i + 1,1 < i < n. The system with the lowest temperature is the 
one of interest. The higher temperature systems are added solely to allow the lowest 
temperature system to escape from local energy minima without explicit knowledge of 
the barriers. Since there are no energetic interactions between the replicas, for the entire 
system, the partition function could be written as 
M „ 
Q = U§iJ dr?exV[-mr?)L (4-6) 
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where & = Y[j'=i(^7rrrij^BTi)^2 is the partition function of system i, rrij is the mass of 
atom j , rf specifies the positions of the N particles in the system i, and U is the potential 
energy of the system i. The swapping move between ensembles % and j is accepted with 
the probability 
acc(i - j) = min{l, exp[(A - fl)(U(rf) - U(rf))]}. (4.7) 
Swaps are generally attempted between systems adjacent in the temperature ladder. 
This method significantly reduces the equilibration time. In order to achieve efficient 
sampling, the maximum temperature is such that no significant free energy barriers are 
observed. Also, to improve the acceptance probability of the swapping moves, the energy 
histograms of adjacent systems are allowed to overlap. 
4.2.4 Hybrid Monte Carlo (HMC) 
The ensemble of Monte Carlo techniques described so far is still inefficient in sampling 
the phase space of highly constrained peptides such as those with disulphide bridges. In 
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order to speed up the proceedings, a HMC move is introduced. 
Monte Carlo simulations allow local moves for searching the conformation space. 
Even with clever moves such as CBMC, updating more than a few particles leads to 
prohibitively low acceptance ratios. Although the stochastic nature of the method ensures 
eventual sampling of the entire phase space of a system, for complex proteins it often fails 
to do so within feasible computer time. The result is poor statistics with large relaxation 
times and high correlations. 
Molecular dynamics simulations propose global moves. The scheme, however, is prone 
to errors and instabilities due to a finite step size. Also, typical MD simulations are run 
for 103 to 104 ps. This time scale is many orders of magnitude smaller than the 10 3 to 
102 seconds range over which many interesting phenomena in protein folding are known 
to take place [96]. 
Hybrid MC method combines the advantages of both MC and MD methods. It allows 
for global moves, but at the same time, it is an exact algorithm that does not suffer from 
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step-size errors. 
A single HMC move of the whole system consists of the following steps. 
1. Initial momenta are generated from the correct equilibrium distribution P(pi) oc 
exp (—f3pi2/2mi). This is achieved by generating a set of Gaussian random numbers 
with unit variance and rescaling them appropriately. 
2. Employing a time reversible and area preserving algorithm, the system is integrated 
through phase space for a fixed time t (we carry out the integration for time greater 
than the first auto-correlation time in the potential energies). The new coordinates 
are accepted with the following Metropolis probability. 
Pacc = m i n ( l , e - ^ (4.8) 
where AH = H(q',p') — H(q,p). H denotes the Hamiltonian of the system; q,q' 
denote initial and final coordinates, and p, p' denote initial and final momenta. 
Since the momenta are influenced by the interaction forces, the coordinates tend to 
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evolve in the direction of the decreasing potential energy. However, as the momenta are 
drawn at random (from a Maxwell-Boltzmann distribution), 'uphill' moves in energy are 
possible. After every HMC move, the momenta are refreshed irrespective of whether the 
move is accepted or not. This is essential in order to satisfy the condition of detail balance. 
The HMC move helps achieve a purely canonical ensemble without compromising the 
inherent stability and exactness of MC simulations. The step size used during the MD 
integration has no bearing on the observables. The discretization error produced is 
accounted for in the acceptance criteria and only affects the acceptance rate. 
For the MD part of the move, all 3AT degrees of freedom are considered. The Newto-
nian equations of motion are integrated using the velocity verlet algorithm [97]. 
4.2.5 Simulation details 
As mentioned in the introduction, four different combinations of the simulation meth-
ods were tried on a test set of four cyclic peptides cyclo(dWdDPdVL), cyclo(dPAAdPAA), 
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cyclo(dPFASFF), and a protein loop region corresponding to residues 1491-1498 (se-
quence: TGRGDSPA) of human fibronection repeat 10 (pdb-entry: 1FNF). In the amino 
acid sequence, d indicates a residue in the D chirality. Each peptide was simulated for 
a million steps in all the four methods. During the CBMC+RG+RB method, backbone 
units and side-chain units were selected with equal probability. The MD was carried 
out in the NVT ensemble. The Anderson [98] thermostat was implemented to keep the 
temperature constant. A time step of 1 fs was chosen for both MD as well as HMC 
moves. Each HMC move was carried out for a modest 100 steps. The temperatures for 
parallel tempering were chosen such that sufficient overlap was obtained between energy 
histograms of adjacent systems. The simulation methods were evaluated on their ability 
to equilibrate different properties of the system, the speed of equilibration, and their 
ability to generate uncorrelated structures. A comparison was also made between sim-
ulations of polyalanine with and without the inclusion of the GBSA model using HMC 
method. 
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4.2.6 Results and Discussion 
Energy histograms during a parallel tempering run of peptide dPFASFF with MD+RG+RB 
method are shown in Figure 4.2. For swapping between adjacent replicas to occur with 
sufficient probability, their energy histograms need to overlap. Table 4.1 lists the accep-
tance probabilities for swapping moves in this run. These values are representative of all 
the 16 e4ff—-+ 
dPFASFF 
Energy histograms in parallel tempering 
200 300 400 
Energy (kcal/mol) 
Figure 4.2 Energy histograms 
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Table 4.1 Acceptance probability for swapping moves in a parallel tempering simulation. 
Swap 
300 K <-> 400 K 
400 K ^ 540 K 
540 K «-> 720 K 
720 K <-» 900 K 
900 K <-> 1170 K 
1170 K •-* 1500 K 
p 
x
 ace 
0.07700 
0.05155 
0.06253 
0.047144 
0.09527 
0.060121 
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Figure 4.3 shows the temperature distribution for the lowest temperature (300 K) 
replica of dPAAdPAA during MD simulation. The Anderson thermostat maintains the 
temperature distribution around 300 K. The figure demonstrates that the MD method 
i c i n Q P P Q g o m r u i n rr r » r » T i f n r T Y t Q + i n n o r r r \ m t n o N T v T ^ O T I C O T V I K I O 
0.02 
0.015 h 
a o.oi 
0.005 h 
dPAAdPAA 
MD with Anderson thermostat 
300 
Temerpature (K) 
Figure 4.3 Temperature distribution during MD simulation. 
The first test for the performance of the simulation methods is that one should get 
identical results for the equilibrium properties from each of the methods for a particular 
peptide. Equilibration of potential energy in all cases is shown in Figure 4.5. For each 
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peptide, energy histograms from all four different methods are the same. 
The energy of the system is an easier property to equilibrate than the radius of gy-
ration, Rg. It is defined as the root mean squared distance of each atom in a peptide 
from its center of gravity, and it describes the overall spread of the molecule. Figure 4.6 
shows equilibration of Rg in all four peptides with all four methods. Histograms in Rg 
for dWdDPdVL and TGRGDSPA are the same from all four methods. However, those 
for dPAAAdPAA and dPFASFF differ from each other. For dPFASFF, the histograms 
from HMC, and HMC+RG-t-RB methods are the same, whereas, those from MD and 
MD+RG+RB are different. The reason for this discrepancy could be traced to the ac-
ceptance ratios between adjacent replicas during parallel tempering. The low acceptance 
values, as seen from Table 4.1 indicate a suboptimal choice of temperatures for the two 
peptides that translates into a lack of equilibration of certain properties. 
Same is true for histograms in torsion angle <f> (C — Ca — N — C') of proline residue 
as shown in 4.7 for these peptides. Histograms for dWdDPdVL and TGRGDSPA are the 
103 
same for all four methods, whereas those for dPAAAdPAA and dPFASFF are different. 
In the case of peptide dPAAAdPAA, it is clear that simulations without the RG and RB 
moves were unable to equilibrate the torsion angle in question. Addition of the CBMC 
moves helped improve the equilibration. 
Figure 4.4 shows the movement of the lowest temperature replica of two peptides, 
dWdDPdVL and dPFASFF, through the temperature ladder during the course of MD+RG+RB 
simulations. One can see that in case of dWdDPdVL the replica was able to jump to 
the higher temperatures much more frequently as compared to the replica for dPFASFF. 
This explains the relative lack of equilibration of Rg and the proline dihedral angle, <f>, 
in dPFASFF. 
At high temperatures though, the system is able to overcome the barriers more easily, 
and the properties are well equilibrated. Histograms in Rg for dPFSAFF at 1500 K (Fig. 
4.8) from all four methods are the same. This is also true for the histograms in proline 
torsion angle <f> for dPFSAFF as seen from Fig. 4.9. Comparison between histograms in 
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Movement through temperature ladder 
dPFASFF 
Movement through temperature ladder 
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Number of steps 
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Number of steps 
F i g u r e 4 .4 Movement of the lowest temperature replica through the temperature ladder 
for dWdDPdVL and dPFSAFF. 
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proline dihedral angle <f> (Fig. 4.10) of dPASFF at 300 K and 1500K shows that at 1500 
K, the distribution of torsion angles is much flatter, and the molecule is free to cross 
the barrier at —100°. Thus, parallel tempering allows the molecule to escape from local 
energy minima where it might otherwise have been trapped. 
The relative speeds of different methods are shown in Table 4.2. 
Table 4.2 Comparison of simulation results of dWdDPdVL in terms of relative CPU time. 
Simulation method 
HMC 
HMC+RG+RB 
MD 
MD+RG+RB 
Number of steps 
1 x 106 
l x 106 
1 x 106 
l x 106 
Relative CPU time 
1.0 
1.5 
1.0 
1.5 
The auto-correlation of an observable in a system shows the similarity between the 
observable as a function of time separation. For an observable 0 , the autocorrelation 
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Figure 4.5 Energy histograms at 300 K for four peptides with four simulation methods. 
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function is given as 
C0(t) = (Ot0+tOt0) - (Of. (4.9) 
Here, 0 i o and Ot0+t are measurements that are separated by t steps. Figure 4.11 shows 
the auto-correlations in the Rg values for the four peptides at 300 K. In all four cases, 
either HMC+RG+RB or MD+RG+RB methods provide the quickest drop in correlations 
as compared to pure HMC and pure MD methods. Addition of CBMC+RG+RB moves 
helps sampling of configurations from different energy basins. A pure HMC move almost 
always seems to be the worst choice in terms of reducing the correlations. Even at 
high temperatures, when the auto-correlation function quickly decays to zero for other 
simulation methods, those from HMC method show longer auto-correlation times (Fig 
4.12). This, however, in part could due to the lower value of time step (1 fs) during HMC 
simulation. This value of the time step yields higher acceptance ratios (> 70%). This is 
too high an acceptance rate that makes the overall simulation less efficient by not being 
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able to sample independent, representative configurations. Using higher values (> 1 fs) of 
time step during HMC simulation could help improve efficiency of the method.. In such 
cases, the increased error in energy conservation due to discretization of the equations of 
motion would be accounted for in the acceptance criteria for the step. 
A clustering algorithm was implemented to look at the configurations that were saved 
after every 104 steps. For each run, 100 configurations were thus saved. Table 4.3 shows 
the number of clusters and configurations in each cluster for the four peptides from each 
simulation. The probability of sampling a particular structure is directly related to the 
number of configurations in that cluster. Figure 4.13 shows representative structures 
from the most probable cluster for dPAAdPAA with different simulation methods. 
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Table 4.3 Peptide configurations clustered according to RMSD (0.75 A) 
Peptide 
dPAAdPAA 
dPFASFF 
dWdDPdVL 
TGRGDSPA 
configurations in cluster 1 
configurations in cluster 2 
non-cluster configurations 
configurations in cluster 1 
configurations in cluster 2 
configurations in cluster 3 
non-cluster configurations 
configurations in cluster 1 
non-cluster configurations 
configurations in cluster 1 
non-cluster configurations 
Number of configurations 
HMC 
62 
34 
4 
59 
38 
0 
3 
100 
0 
98 
2 
HMC+RG+RB 
58 
40 
2 
56 
15 
22 
7 
100 
0 
99 
1 
MD 
70 
27 
3 
70 
17 
13 
0 
100 
0 
98 
2 
MD+RG+RB 
50 
49 
1 
53 
34 
8 
5 
100 
0 
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Figure 4.12 Auto-correlations in Rg at 1500 K for dPFSAFF 
Implicit solvent model 
In computer simulations of biological molecules, solvent environment plays an impor-
tant role. Structure, dynamics, and energetics are all influenced by the solvent. The most 
accurate way to account for solvent effects is to use the explicit solvent models. Such 
models use large number of discrete solvent molecules to simulate the liquid environment 
[99, 100, 101]. These models, however, do suffer from convergence problems with the 
required computational times being 100-1000 times more than those involving gas phase 
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Figure 4.13 Representative structures from most probable clusters of dPAAdPAA from 
four simulation methods. Clockwise from top left, the methods that generated the structures 
are, HMC, HMC+RG+RB, MD and MD+RG+RB 
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molecules [102]. In order to lower the computational cost of including solvent effects, 
an implicit description of solvation is generally used to replace the explicitly modeled 
solvent molecules. The implicit description approximates the high dielectric solvent by 
a continuum electrostatics model. The generalized-Born (GB) model [103] is one such 
model. This model has been implemented and was tested on alanine dipeptide. The HMC 
method was used to simulate the system without parallel tempering. The simulation was 
carried out for a 105 steps. The results from the simulation were compared with HMC 
simulation where the GB energies were considered only during the acceptance criteria. 
Both methods satisfy detailed balance. The results comparing energy histograms, Rg his-
tograms, and one C' — Ca — N — C' torsional angle are represented in Figure 4.14. The 
two sets of simulations provided equivalent results for the potential energy and backbone 
torsion angle. Here again, Rg proved to be the more difficult property to equilibrate. 
Also, the simulation using the GB forces was nearly 12 times slower than one that used 
GB energies only during the acceptance criteria. 
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Figure 4.14 Histograms in energy, Rg, and the C — C a — N — C (<j>) torsion angle for 
alanine dipeptide for two sets of HMC simulations. One model uses forces due to GB energy 
during the simulation, whereas, the other only uses GB energies in the acceptance criteria. 
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4.2.7 Conclusion 
Four different combinations of simulation methods have been used to equilibrate four 
different cyclic peptides. The HMC and and the MD methods augmented with RG+RB 
moves show considerable improvement in sampling independent configurations. Parallel 
tempering method helps the peptides escape the local energy minima through swapping 
moves as is clearly seen from the flatness of the histograms at higher temperatures. Of 
the four peptides, dWdDPdVL was equlibrated the easiest as evidenced from the various 
histograms and the fact that all the configurations could be collected in a single cluster for 
all four simulation methods. The peptide dPFASFF proved to be more difficult judging 
from the longer correlation times and histograms in Rg. It was also the only peptide that 
was found to have three representative structures that were separated from each other 
by at least 0.75 A. 
There are several variables that could be adjusted depending on the system involved, 
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for example, more weight to side chain moves than backbone moves in RG+RB for 
peptides with bulky side chains, the range through which the driver angles are rotated 
during the analytical rebridging move to cause bigger changes per move etc. Also, choice 
of temperatures for the parallel tempering run should be optimized for each system. 
Combination of these simulation techniques along with implementation of GB models 
would be useful for studying more complex systems such as the cysteine-rich peptides 
with criss-crossing disulphide-sulfide bridges. 
Chapter 5 
Probing the role of Cripto in the regulation of 
E-cadherin with docking methods 
5.1 Introduction 
Human teratocarcinoma growth factor (TDGF1), or Cripto, is a small membrane-
linked molecule that acts as a soluble growth factor when shed into the extracellular 
environment. Cripto is a membrane-bound co-receptor in tumor growth factor (TGF)-
signaling, and it has previously been isolated from a pluripotent cancer cell line, NTERA2, 
and is now considered an oncogene. Cripto is a member of the epidermal growth factor 
(EGF) - Cripto/FRL-1/Cryptic (CFC) gene family. The human and murine Cripto genes 
display 94% homology in the EGF-CFC domain, whereas the sequences of the N- and 
C-terminal regions are unique [104]. More recently, Cripto expression has been described 
to be part of a 'pluripotency signature' of several progenitor cells [105, 106, 107]. 
A research group at M. D. Anderson cancer center at the university of Texas recently 
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examined TDGF1 expression in human bladder urothelial carcinoma cell lines and found 
that it was expressed in the cytosol and nucleus of highly invasive bladder cancer cells 
and that it was associated with no expression of E-cadherin (E-cad) [108]. It was demon-
strated that the nuclear form of human Cripto (truncated form) binds histone deacetylase 
(HDAC)-l and -2 and Snail with which it cooperates in inducing the loss of E-cad expres-
sion and increases the promoter-targeted HDAC activity. Using human tissue samples 
it was also showed that the nuclear form of Cripto possibly plays an important role in 
bladder cancer progression. This was the first study to report that Cripto regulates of 
E-cad expression when in the nucleus. 
This chapter describes part of aforementioned study that explored the possibility 
of specific DNA binding 'signature' to Cripto within the E-cad promoter, and the role 
played by Snail in DNA-Cripto interactions from a computational point of view. To that 
end, docking studies were carried out between homologs of Cripto, Snail, and the DNA 
fragment. The results were compared with experimental findings. 
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5.1.1 Docking 
Molecular docking tries to predict the structure of receptor-ligand complexes. The 
receptor is normally a protein molecule, and the ligand might be either a small molecule 
or another protein. Over the years, molecular docking has evolved from a tool to repro-
duce the crystal structures of known molecular complexes [109] into a tool that is used 
extensively in rational drug design, for tasks such as optimizing lead compounds through 
database screening, and pre-screening real or virtual compounds to design combinatorial 
libraries [110]. 
The docking algorithm contains two important steps. The first step involves a thor-
ough search of the conformational degrees of freedom of the molecules involved, and 
the second step assigns an appropriate docking score to rank the conformations thus 
searched. In general, the molecules are treated as rigid bodies in docking. The search 
algorithm explores different orientations of the ligand molecule in the experimentally 
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known receptor active site using translational and rotational degrees of freedom. Ideally, 
the search algorithm should be able to locate the global energy minimum for the system. 
The scoring function tries to assess both steric as well as chemical complementarity of 
the different configurations. It should be realistic enough to assign the lowest score to 
the experimentally determined complex structure. 
Over the years, many research groups have tried to come up with docking algorithms 
that balance the contradictory requirements of speed and accuracy. In early days, docking 
program represented both receptor and ligand with explicit atoms [111]. Such represen-
tation resulted in numerous complex configurations, all of which needed to be evaluated. 
The applications of molecular surface calculations [112] in docking algorithm reduced the 
number of possible complexes significantly, thus increasing the search speed. The next 
major update came from the application of grids to store receptor properties. With the 
assumption of rigid receptor, the grid needed to be calculated only once. DOCKER [113] 
and GRID [114] were two of the early programs that incorporated the grid method in 
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their algorithms. Flexibility in ligand molecule was the next step in terms of improving 
the search for the native conformations. Since the knowledge of ligand orientation that 
interacts most favourably with the receptor is often missing, this was an important devel-
opment. These algorithms used one or more of three types of search methods, systematic 
[115], stochastic [116], and deterministic [117]. The systematic search methods relied on 
combinatorial search of grid values of each degree of freedom. The stochastic methods 
relied on random changes in degrees of freedom. These included Monte Carlo methods 
[116], and evolutionary algorithms [118]. The deterministic search methods on the other 
hand used initial state values to generate the next state to go downhill in energy space 
in search of the global minimum. Allowing for receptor flexibility was the next logical 
progression. Researchers have showed that methods allowing for receptor flexibility could 
improve the success rate of locating the native structures by as much as 25% in certain 
cases [119]. Programs that treat both receptor and ligand in a flexible manner are useful 
when the structure of either molecule undergoes conformational changes due to induced 
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fit. 
Protein-protein docking is a more difficult task compared to protein-small molecule 
docking. Not only is the number of generated complexes huge, but also prediction of 
protein interacting site is a difficult task. The scoring function needs to be rather soft 
because even in near-native configurations, some atoms are likely to clash. Often the 
scoring takes place in two stages. A geometric filter eliminates those conformers that are 
unlikely to be complex structures in the first stage. In the second stage, geometrically 
feasible conformers are scored with a more elaborate energy function. This study uses 
one such algorithm designed for protein-protein docking called Hex. 
5.1.2 Hex 
Hex [120] is an interactive protein docking and molecular superposition program, writ-
ten by Dave Ritchie. The program approaches a docking problem through representation 
of the steric shape, electrostatic potential, and charge density of each protein as expan-
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sions of spherical polar Fourier basis functions. Unlike three-dimensional fast Fourier 
transform docking approaches that accelerate translational correlations, Hex favours ro-
tational searches. The original shape-sampling algorithm and the improvements are 
described in [121, 120]. This method was able to locate conformations from top 20 solu-
tions in four of the seven target protein-protein complexes in the 'critical assessment of 
predicted interactions' (CAPRI) blind docking trial [121]. 
Docking large molecules 
Since the radial basis functions fall off rapidly beyond 30 A from the origin, the 
spherical polar approach by itself is incapable of handling large protein molecules. Hex is 
able to generate multiple local coordinate systems with which the initial ligand docking 
orientations about a large receptor are generated. The docking process is a four step 
procedure described as follows: 
1. The smaller molecule is oriented to face the receptor. 
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2. A low resolution spherical harmonic surface is calculated for the receptor. By 
projecting the surface onto an icosahedral tessellation of the sphere, the surface is 
discretized. A normal vector is calculated at each triangular facet of the surface, 
and a sphere of 15 A radius is centered on each outward pointing normal, tangential 
to the surface. The step smothers the receptor surface with spheres. 
3. In order to get an even distribution of spheres over the receptor surface, the surface 
spheres are culled through iterative identification and removal of a sphere that has 
the most volume overlap with its neighbours. The iteration continues untill no 
sphere with a volume overlap of more than 5 A is left. 
4. Each remaining sphere (normal vector) is used to define a local intermolecular axis 
for docking. 
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Soft molecular mechanics refinement 
In order to reduce the number of false positives, Hex implements a scoring function 
with Lennard-Jones (12-6) and hydrogen bond (12-10) terms that are constructed from 
the OPLS force field [122]. The parameters are modified so as to retain the long range 
nature and minima of the original set, but to reduce the short-range repulsive behaviour. 
The correlation search is followed by energy minimization of the first five hundred orien-
tations. The final docking score is thus a sum of the soft scoring function and shape-based 
correlation energies. 
-Etotal = -Eshape + -EoPLS (5.1) 
Solution clustering 
The procedure to smother the surface of macromolecules tends to over-sample the 
orientational search space. Hence, all low energy orientations are clustered so as to 
identify distinct orientations. After ordering the solutions in order of increasing energy, 
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the clustering algorithm uses the lowest energy orientation as the seed for the first cluster. 
The rest of the orientations are searched to find entries where the Ca atoms of the ligand 
fall within 2 A rms of the corresponding atoms in the seed member for the current cluster. 
The procedure is repeated until all solutions are allocated to a cluster. This process is 
useful to avoid a good solution being pushed down the order in the final list. 
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5.1.3 Methods and results 
The E-cad promoter was divided into 4 regions namely PI, P2, P3, and P4. Since 
crystal structures of both Cripto and Snail were unavailable, a homology search was 
carried out using 3D-PSSM [123], a fold recognition server. For Cripto, a 101 residue 
chain L of coagulation factor VIIA [124] (amino acid homology 21%), and for Snail, an 
83 residue chain C of zinc finger protein [125] (amino acid homology 45%) were selected 
as suitable homologs. Three dimensional structures of the selected compounds were 
retrieved from the protein data bank. Heteroatoms and water molecules were removed 
from the respective pdb files. The DNA fragments PI and P4 were modeled and energy 
minimized using standard B-DNA geometry with sibyl-7.1 [126], a computational tool 
kit for molecular design and analysis. The following three systems were studied using 
HEX. 
1. P1-1DVA 
133 
2. P4-1DVA 
3. P4-1MEY-1DVA 
The sequences for the DNA fragments, the two proteins, and their respective homologs 
are provided below. 
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The DNA sequence (double stranded DNA oligos) used for EMSA 
PI: GGTAC GGGG GCGGT 
P4: GCTCC GGGGC TCACC TGGCT GCAGC CAC 
Sequence of protein Cripto: 
MDCRK MARFS YSVIW IMAIS KAFEL GLVAG LGHQE FARPS RGYLA FRDDS 
IWPQE EPAI RPRSS QRVPP MGIQH SKELN RTCCL NGGTC MLGSF CACPP 
SFYGR NCEHD VRKEN CGSVP HDTWL PKKCS LCKCW HGQLR CFPQA FLPGC 
DGLVM DEHLV ASRTP ELPPS ARTTT FMLVG ICLSI QSYY 
Sequence of chosen homologous protein exosite inhibitor E-76 (PDB code 
1DVA; chain L similarity 21%): 
ISYSD GDQCA SSPCQ NGGSC KDQLQ SYICF CLPAF EGRNC ETHK DDQLIC 
VNENG GCEQY CSDHT GTKRS CRCHE GYSLL ADGVS CTPTV EYPC GKIPIL 
E 
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Sequence of the protein Snail: 
MPRSF LVRKP SDPNR KPNYS ELQDS NPEFT FQQPY DQAHL LAMP PPEIL 
NPTAS LPMLI WDSVL APQAQ PIAWA SLRLQ ESPRV AELTS LSDED SGKGS 
QPPSP PSPAP SSFSS TSVSS LEAEA YAAFP GLGQV PKQLA QLSEA KDLQA 
RKAFN CKYCN KEYLS LGALK MHIRS HTLPC VCGTC GKAFS RPWLL QGHVR 
THTGE KPFSC PHCSR AFADR SNLRA HLQTH SDVKK YQCQA CARTF SRMSL 
LHKHQ ESGCS GCPR 
Sequence of the homologous zinc finger protein (PDB code 1MEY; chain C 
similarity 45%): 
MET GLU LYS PRO TYR LYS CYS PRO GLU CYS GLY LYS SER PHE SER GLN 
SER SER ASN LEU GLN LYS HIS GLN ARG THR HIS THR GLY GLU LYS PRO 
TYR LYS CYS PRO GLU CYS GLY LYS SER PHE SER GLN SER SER ASP LEU 
GLN LYS HIS GLN ARG THR HIS THR GLY GLU LYS PRO TYR LYS CYS PRO 
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GLU CYS GLY LYS SER PHE SER ARG SER ASP HIS LEU SER ARG HIS GLN 
ARG THR HIS GLN ASN LYS LYS 
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As per convention, the larger molecule (DNA fragment) is referred to as receptor and 
the smaller one (protein homologs) are referred to as ligands. Owing to the large size 
of the molecules involved, the macromolecular docking option was used in each case. 
A sphere smothering algorithm generated multiple local coordinate systems with which 
initial ligand (protein) docking orientations were defined about the receptor (DNA). For 
each target, the algorithm performed an initial low-order shape complementarity scan. 
The best 10000 orientations were then refined by using high-order shape correlations. 
The top 500 orientations from each high-order correlation were energy minimized and 
clustered to get a final list of distinct docking orientations. The top 5 orientations were 
inspected in each case to identify the DNA residues interacting (< 2.5 A) with the protein 
ligand. In order to investigate the possibility of existence of a complex containing Cripto 
and Snail, docking was carried out between P4 and 1MEY. The orientation where 1MEY 
was found interacting with the E-box on P4 (2nd lowest energy) was selected as the new 
receptor for docking 1DVA. 
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Table 5.1 lists the energies (docking score) and DNA bases that interact with the 
peptide ligands for the top 5 conformations for 1MEY-P4-1DVA, and 1DVA-P1 systems. 
DNA bases and residues on ligands within a distance of 2A of each other were considered 
to be interacting. 
Figure 5.1 shows the lowest energy conformation for the 1MEY-P4-1DVA complex. 
5.1.4 Discussion and conclusions 
The results from the docking study provide interesting insights in the context of the 
experimental observations recorded in [108]. Gel-shift assays carried out with Cripto and 
E-cad promoter have showed that Cripto interacts with PI, but not with the P2 or P3 
regions. The PI region contains a CGGG sequence specific for binding of transcriptional 
activators of the E-cad promoter [127, 128]. Two of the top five orientations for the 
1DVA-P1 system showed CGGG to be a potential interaction area between these two 
molecules. 
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Table 5.1 Energies and ligand interacting DNA base pairs in the top 5 orientations for the 
systems of P4-1MEY-1DVA and P1-1DVA. 
1MEY-P4-1DVA 
Orientation rank 
1 
2 
3 
4 
5 
Docking score (kJ/mol) 
-578.1 
-559.7 
-558.6 
-552.7 
-537.9 
Iinteracting DNA (P4) base pairs 
7-10 
19-20 
7-9 
19-20 
2-4 
1DVA-P1 
Orientation rank 
1 
2 
3 
4 
5 
Docking score (kJ/mol) 
-509.8 
-477.2 
-468 
-463 
-461.2 
Interacting DNA (PI) base pairs 
8-10 
7-9 
8-10 
10-13 
3-7 
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F igure 5.1 Lowest energy orientation for 1MEY-P4-1DVA system. 
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The addition of an anti-Cripto antibody induced a 'sub-shift' of the molecular complex 
that binds the E-cad promoter sequence in the P4 region, suggesting the loss of one or 
more interacting proteins from the complex. Similarly addition of the anti-Snail antibody 
induced a similar shift of the same complex, suggesting that Cripto and Snail are parts 
of the same complex that binds the E-cad promoter sequence P4. The binding of Snail 
protein to the P4 region was showed to be dependent on the integrity of the so called 
E-box (CACCTG). Mutations of the type C to T in the E-box abolished the binding 
between Snail and P4. This was the reason behind selecting the low energy 1MEY-
P4 complex as the receptor for the Cripto homologue, 1DVA. In four of the top five 
orientations for the 1MEY-P4-1DVA system, the 1DVA molecule was found interacting 
with the GGCT base pairs flanking both ends of the E-box. This suggested that presence 
of Snail could increase Cripto affinity and that these two proteins could be part of a 
complex. The predicted interaction between Snail and Cripto has since been confirmed 
through experiments [108]. 
142 
To conclude, preliminary docking study performed on homologs of Cripto and Snail 
proteins and E-cad promoter corroborate experimental findings suggesting that Cripto 
plays an important role in regulating E-cad expression through some promoter priming 
mechanism. It is important to remember that the homology between Cripto and 1DVA 
is on the lower side (< 30%). Also, the docking algorithm for larger molecules are yet in 
the early stages of development in terms of their ability to exhaustively search the large 
number of possible orientations. Lack of proper description of the solvent effects is yet 
another drawback of the method. These factors urge caution in overstating importance 
of the results thus obtained. 
Chapter 6 
Computer-assisted vaccine design 
6.1 Introduction 
Circulating influenza virus uses the ability to change its surface proteins, along with 
its high transmission rate, to flummox the adaptive immune response of the host. The 
random accumulation of mutations in the hemagglutinin (HA) and neuraminidase (NA) 
epitopes, the regions on surface of the viral proteins that are recognized by host antibod-
ies, poses a formidable challenge to the design of an effective annual flu vaccine. Under 
current practice, the World Health Organization (WHO), and the respective government 
health agencies rely on historical experience and phylogenetic analysis of HA and NA 
protein sequences from the circulating human strains to decide the components in the 
annual influenza vaccine [129]. Every year, the concerned authorities make a projection 
about the circulating influenza strains for the coming flu season. The flu vaccine currently 
contains three strains that are as similar as possible to those strains that are predicted 
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to be the most prominent. At present, the three strains in the vaccine are one H3N2 
A, one H1N1 A, and one influenza B component. Historically, the vaccine efficacy has 
seldom reached the 100% mark. Over the years, it has hovered between 30-60% against 
influenza-like illnesses. In fact, due to a phenomenon known as the 'original antigenic sin' 
[130, 131, 132], the vaccine efficacy has even been negative at times. If original antigenic 
sin is operative, the host antibodies that are produced in response to a viral strain tend 
to suppress creation of new and different antibodies in response to a different viral strain. 
Whether such a phenomenon takes place or whether the vaccine is effective depends to 
a great extent on how similar the vaccine component strains are to the circulating viral 
strains. The methods employed to calculate such an antigenic distance draw heavily from 
the ferret antisera hemagglutinin inhibition assays. It has been assumed that the anti-
genic distance thus obtained from ferrets correlates well with the efficacy of the influenza 
vaccine in humans. However, to our knowledge there is limited evidence in the literature 
of such correlations. 
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We introduce a new and effective way of measuring the antigenic distance between dif-
ferent strains. We define a quantity, pepitope, that measures the difference between the 
dominant epitope of the H3N2 vaccine component and the dominant circulating viral 
strain. A dominant epitope is one that elicits the most significant response from the 
adaptive immune system for a particular strain in a particular year [133, 134, 135, 136]. 
We show that for data spanning last 35 years, pepitoPe correlates better with the efficacy 
studies in humans of the influenza vaccine than do the current measures of antigenic 
distance, even those derived from ferrets. 
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6.2 Methods 
We have developed a statistical mechanics based theory to model the response of an 
immune system, free of immunoscenescence, to disease and vaccination. We compare 
this theory to experimental studies of vaccine efficacy for 18-64 year old subjects over the 
past 35 years, when the H3N2 subtype of influenza A was the dominant strain. H3N2 
is the most common stain and has caused significant morbidity and mortality. As is 
the norm, we focused on the five epitopes of the hemagglutinin protein. We used the 
generalized NK model to calculate the affinity constants quantifying the immune response 
following exposure to an antigen after vaccination. The model takes into account three 
types of interactions within an antibody. These include interactions within subdomains, 
interactions between different subdomains, and interaction between an antibody and an 
antigen [137]. The binding constant is given as K = exp (a - b<U>), where U is the 
energy function of an antibody [132], a = -18.56, and b = 1.67. The values of the 
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constants are determined after comparing the dynamics of the model with experimental 
results [132]. In order to capture the antigenic distance between the vaccine strain and 
the circulating strain, we use pepitope as an order parameter in our model. It represents 
the fraction of amino acids that differ between the dominant epitope regions of the two 
strains. 
number of amino acid differences in the dominant epitope 
total number of amino acids in the dominant epitope 
In order to build the model we needed the identity and sequence of the dominant 
epitope in both, the candidate vaccine and the circulating strain. This definition of 
the five epitopes in the H3N2 hemagglutinin protein was taken from reference [138]. 
Our model assumes the following correlation between the vaccine efficacy, E, and the 
binding constants: E = a In [.^ secondary (^ epitope) /-^ primary], where the constant a is selected 
such that a perfect match between the vaccine and the circulating strain corresponds to 
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a vaccine efficacy of 45%. This model is in agreement with the historical data [139]. 
-^ primary is the binding constant corresponding to the primary immune response, and 
-^ secondary is the binding constant corresponding to the secondary immune response that 
follows vaccination. Other than the constant, a, no parameter was fitted to data, making 
the model predictive. For example, the point where vaccine efficacy becomes zero is 
independent of the value of a. 
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6.3 Results 
Table 6.1 compares vaccine efficacy values from experimental studies [140, 141, 142, 
143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153] and predictions from our theory as 
a function of pepitope- In literature, vaccine efficacy is defined as 
Efficiency = , 
where u and v are the influenza-like illness rates in unvaccinated and vaccinated in-
dividuals, respectively. The epidemiological estimates of u and v contain some noise; 
however, these are the best estimates there are of influenza vaccine efficacy in humans. 
Our model demonstrates the effectiveness of using pepitoPe as a measure of antigenic 
drift between the circulating strain and the vaccine strain. Crystallographic data and 
immunoassays have shown that only the epitope regions of the viral proteins are signifi-
cantly involved in the recognition of the antigen via the antibodies [154]. Our definition 
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of e^pitope follows from this observation. When pepitope value in the dominant epitope is 
greater than 0.19 according to experimental records or is greater than 0.22 according to 
our theory, the efficacy of the influenza vaccine drops to the negative territory [Table 6.1 
and Fig. 6.1] indicating that while designing the vaccine, this regime needs to be avoided. 
As an example, during the 1997/98 influenza season in the Northern hemisphere, when 
the Sydney/5/97 strain was widespread, the value of pepitope was 0.238 resulting in an 
efficacy of -17% [148]. Only one data point falls outside our theoretical predictions, 
that for the 1989/90 epidemic [155]. During that year there were likely multiple strains 
circulating, including the strains of influenza B [143, 156]. 
The WHO uses as a first approximation an alternative definition of the antigenic drift. 
It considers the sequence difference of the entire hemagglutinin protein of the circulating 
and viral strains. 
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as a function ^epitope- A linear least squares fit to the data is also shown (long dashed, i?2=0.81). 
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number of amino acid differences in the sequence 
p _ 
sequence total number of amino acids in the sequence 
The correlation with the experimentally observed efficacy is not as positive when 
using the WHO definition for the antigenic distance. This could be seen from Table 6.1 
and Fig. 6.2, and it follows from the fact that many domains in the protein are either 
inaccessible to the human antibodies or simply unrecognizable by them. This results in 
the vaccine efficacy and the drift in the entire protein sequence being not as correlated 
with the approximate measure of distance in Eq. 3. 
The gold standard measure of antigenic drift is that derived from ferret antisera 
[140,157]. Comparison of the vaccine efficacy to this measure of antigenic drift also shows 
less than ideal success. From Table 6.1 and Fig. 6.3, the hemagglutinin assays in ferret 
antisera are unable to capture a significant amount of human efficacy information. For 
example, an antigenic distance of zero according to ferret antisera experiments does not 
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mean that the two strains are identical. As an example, for the 1996/97 season, the ferret 
antisera derived antigenic distance between the vaccine strain of A/Nanchang/933/95 and 
the circulating strain of A/Wuhan/359/95 was zero, whereas pepit0pe value was 0.095. The 
corresponding vaccine efficacy in the Northern and Southern hemispheres was 28% [150] 
and 11% [149], respectively. When compared to the average corresponding to a perfect 
match between the vaccine strain and the circulating strain, which is 45%, these values 
are clearly much lower. 
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6.4 Discussion 
The design of influenza vaccine is always in a race against time. Currently, under the 
supervision of the WHO and the national health agencies, in the Northern hemisphere, 
the components of the annual influenza vaccine are determined between February and 
April. The mass production of the vaccine is then carried out by growing the virus in 
hen's eggs. After the regulatory tests in mid-July, the vaccine is distributed in September. 
Data are collected to determine the vaccine efficacy from October. By January a good 
measure of the effectiveness of the season's vaccine is obtained. Choice of the vaccine 
strain is contingent up on various biological and manufacturing constraints. For example, 
among the egg-cultured strains, the availability of high growth strains is an additional 
criterion. The organizations in charge have to weigh in all these constraints before they 
decide on the best match for the anticipated circulating strain for the following flu season. 
The Pepitope measure of antigenic distance can influence and improve the vaccine design 
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process in two ways. First, it can help identify the strains to be included in the annual flu 
vaccine. For every season, given a list of strains and their probabilities of outbreak, the 
value of Epitope can help define the weighted distance of a particular vaccine strain from 
the circulating strains. This procedure will enable us to identify the vaccine strain closest 
to the strains causing a possible outbreak. Alternately, pepitope can also help identify the 
'like' strains. Various manufacturing constraints in the vaccine production process mean 
it is often not feasible to grow large quantities of the exact strain that is desired for 
the annual vaccine. Under such scenario, it is required to choose several strains that are 
similar to the chosen one. The value of pepitoPe can help quantify the 'likenesses' of a given 
strain to the desired strain. We can extend this approach to other strains of influenza 
as well. Using information about the epitope regions of other HxNy strains of influenza 
A or influenza B, we can calculate the value of e^pitope to quantify the antigenic distance 
for these strains of influenza. 
It is clear that the immune system response is neither linear nor monotonic in the 
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antigenic distance. As a result, the original antigenic sin leading to a negative vaccine 
efficacy exists only in an intermediate regime of the antigenic distance. If the vaccine 
falls in this regime, however, it makes the vaccinated individual more susceptible to 
influenza-like illnesses compared to an unvaccinated individual. Over the past 33 years, 
this phenomenon seems to have taken place 26% of the time for the relevant H3N2 
strains from the epidemiological data (as indicated by 5 of the total 19 data points that 
are negative in Table 6.1 and Fig. 6.2). The negative points are not necessarily a result 
of experimental errors; rather they may have their roots in the phenomenon where the 
immune system is unable to distinguish between the new and the old viral strains. It 
is desired that the regime corresponding to the original antigenic sin is avoided, not 
only for the obvious immunological consequences, but also for the negative impact it 
creates against the acceptance of public health policy. Our theory rightfully captures 
the underlying physics of immune response, and corroborates the experimental findings. 
Our theory and pepitope measure of antigenic distance can be used to ensure that vaccines 
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chosen would not fall in the original antigenic sin region against expected strains. 
It appears that e^pitope is a better measure of the antigenic distance between viral 
strains than the sequence analysis or the ferret antisera. The population at large may 
benefit if the health authorities incorporate pepitope in the prediction and design of the in-
fluenza vaccine in addition to (or even instead of) the current practices. We now present 
a few examples to show how our theory can assist shaping public health policies. Here we 
examine the 2004/2005 flu season in the Northern hemisphere. With the aid of e^pitope 
we can stipulate a priori the extent of protection a particular vaccine strain provides 
against the circulating strain for a particular season. The comparison among various 
candidates would provide us selection criteria for their inclusion in the annual flu vac-
cine. During the 2003/2004 flu epidemic, A/Fujian/411/2002 strain was predominant. 
In order to counter that strain, the Advisory Council of the FDA recommended using 
A/Wyoming/2003 as the H3N2 component of the 2004/2005 vaccine [158]. According 
to the prevalent measures, this strain and A/Fujian/411/2002 were found to be 'anti-
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genically equivalent.' Our calculations, however, yielded a pepitope value of 0.095 for the 
pair in question, suggesting that the two strains were not antigenically equivalent, and 
the predicted efficacy is 20% (Fig. 6.1). The vaccine efficacy that year was roughly 20% 
[153, 159]. We note that another of the WHO approved candidates for that year was 
A/Kumamoto/102/02 (ISDN38180) [160], and we found pepitoPe value to be zero versus 
A/Fujian/411/2002. According to our theory, a vaccine constituting this strain would 
have provided a better protection against the Fujian as compared to the Wyoming strain. 
The vaccine efficacy that year was a modest 28% [159]. 
As another example, we consider the 2008/2009 flu season in the Northern hemisphere. 
The reference vaccine strains for the 2007/2008 season were A/Wisconsin/67/2005 or 
A/Hiroshima/52/2005 [161]. For the 2008/2009 season, although some isolates were 
antigenically similar to the Wisconsin strain, the majority of the isolates were distin-
guishable from it, and more similar to A/Brisbane/10/2007 strain [162]. According to 
our analysis, the pepitope value between Wisconsin and Brisbane strains is 0.1579. This 
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suggests that the people who were vaccinated with the Wisconsin strain will have a low 
level protection against the Brisbane strain, and will need vaccination with the WHO 
recommended Brisbane-like virus [162]. Similarly, the pepitope value for the pair of Bris-
bane and Hiroshima strain turns out to be 0.095. People vaccinated with Hiroshima 
strain a year earlier are expected to fare better than those vaccinated with Wisconsin 
strain; however, the protection level is still low enough to recommend vaccination with 
a Brisbane-like strain. Thus, pepitope rnay help authorities decide when changes to the 
vaccine are necessary. 
6.4.1 Suggestions to improve predictability of vaccine efficacy 
At the heart of our approach lies the identification of the dominant hemagglutinin 
epitope recognized in humans. The identity of the dominant epitope for humans is 
currently not measured. We define and postulate the dominant epitope for humans 
for a certain strain and for a certain season as the epitope that undergoes the largest 
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fractional change in the sequence of amino acids in comparison to the vaccine strain. A 
measurement of the epitope that is dominant in humans for various circulating strains 
and vaccines should help improve the predictive power of our approach even more, as 
we can then use the measured dominant epitope to calculate pepitope instead of using our 
postulated dominant epiotope. It is important to continue measurement and sequence 
analysis of the prominent circulating strains in the flu season. Another important piece of 
the puzzle is the epidemiological study that relates vaccine efficacy to the antigenic drift. 
We believe that continuous efforts in these areas would enable the health authorities 
predict the severity of the yearly flu season, design better vaccines for the same, and help 
manage the health resources for this period. 
In more general terms, the results presented here have implications for the fight 
against diseases that stem from rapidly mutating viruses and that are managed through 
antibody responses. The pepitope measure of antigenic distance can predict efficacy for 
vaccine strains against multiple circulating strains, and it could then be used towards 
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redesigning of the vaccine in terms of frequency and composition. One such disease that 
has been threatening to turn into a pandemic of late is the avian influenza or bird flu 
disease. In the next section, we present a multiple-strain transmission model for avian 
influenza that would enable one to manage the risk from such an outbreak. We use e^pitope 
to evaluate the effectiveness of a multiple-component vaccine to counter such threat. 
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6.5 Vaccination strategies and risk management of flu pan-
demic 
Since its first appearance (Hong Kong, 1997), H5N1 avian influenza is known to 
have spread to various parts of the world, including South-East Asian countries, parts 
of central and Middle-East Asia, Africa, and Europe. This rapid spread has prompted 
the World Health Organization (WHO) to suggest that "we are closer to a pandemic 
than at any time since 1968 [163, 164]." Bird flu has been observed in pigs [165], and 
occurrences of person-to-person transmission have likely been detected [166, 167, 168]. 
Efficacy of the vaccine produced against the original Hong Kong strain of H5N1 has been 
poor against some of the new strains. In addition, the high mutation rates observed 
in the avian influenza have raised the prospect of simultaneous introduction of multiple 
strains [164, 169, 170, 171], putting a question mark against the efficacy of a single-
component vaccine. Although in the event of appearance of multiple strains, eventual 
emergence of a single dominant strain is likely; the lack of a priori knowledge of which 
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strain will be dominant makes it worthwhile to look into the alternative of a multiple-
component vaccine. Here, we use an epidemiological model to study the efficacy and 
cross-protection of a multiple- component bird flu vaccine. We further extend the concept 
of 
Pepitope through a stochastic model to manage the risk of a flu pandemic. The strategy 
is inspired by similar risk management studies in finance, and pepitope plays the role of 
the risk variable. 
6.5.1 Multiple-strain introduction transmission model 
As mentioned above, there is evidence, both theoretical and otherwise that deems 
introduction of multiple-strains of avian influenza as a distinct possibility. There have 
been no mathematical models, however, that explore such a scenario and suggest compe-
tent vaccine strategies. Our model uses the concepts of hierarchical scale free network, 
and virus transmission, and viral evolution to take into account possible, and worst case 
scenarios and to provide answers to the questions posed by the same. 
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6.5.2 Hierarchical scale free network 
We divide the total human population (6.7 x 109) into (6.7 x 106) groups. Each group 
consists of 103 people that exhibit similar health status and social behavior. These groups 
are distributed over Ncity cities. The distribution of cities with i groups iVcity(z) goes as 
-Ncity(i) oc i~21 [172, 173]. The largest and the smallest city areas in our simulation have 
6.2 x 104 and 400 groups respectively [173]. The total number of cities fluctuates around 
4000 [174]. 
The cities are connected through a network that extends globally and is defined by 
the network spawned by the airlines. The distribution of cities with i contacts is given 
by ./Vcity_contact(i) oc i~20. The network connecting groups within a city is defined by the 
ground transportation network. In each city, the distribution of groups with i contacts 
is given by iVgroup_contact(i) oc i~2'8 [175]. Population size differences between cities mean 
that movement from one city to another leads to a final averaged distribution over cities 
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that is different for different contact numbers. 
6.5.3 Virus transmission and evolution 
In our simulation, the viruses are introduced in groups that are chosen randomly. The 
virus has a latency period of 2 days, which is followed by the infectious period. During 
the infectious period, the virus can either be killed by the host immune system, or it 
can be transmitted between different groups globally. During both these periods, the 
virus can mutate as well as be killed. The term .Rotation = 1.6 x 10_5/amino acid/day 
[176] gives the mutation rate, whereas, the virus killing rate cKill is a function of the 
host immune history as well as the identity of the infecting virus. The transmission rate 
takes into account the seasonal effect [177], and is different for transmission within a 
city (Ffacl xroX (1+0.25 sin(2 7r T/360)), Ffacl=1.0) and transmission between cities 
(Ffac XT0X (1+0.25), Ffac=7.0). Ffac is the number of different groups that people 
traveling on a flight come from, and it is set to 100 for our model. The term To is the 
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intrinsic transmission ability of the virus, and equals 0.07 for the virus introduced on 
day 1. The mutants, once created, can transmit according to probability cProb. For a 
baseline parameter, cProb equals 0.26. 
6.5.4 Vaccination Strategies 
As an example, for a very rapid public health policy response, we consider that after 
40 days, individuals are vaccinated. We consider single-component as well as multiple-
component. In single-component case, the most dominant strain at day 10 is taken as 
the vaccine strain, whereas, for multiple-component case, the top 10 strains that are 
most dominant on day 10 are incorporated into the vaccine. Day 10 is taken as the 
data collection day by public health authorities. We calculated the efficacy and the 
cumulative attack rates for both cases. Efficacy is defined by equation 2 above. Thus, 
efficacy represents the percentile reduction in disease occurrences in people who were 
vaccinated compared to those who were not [178, 179]. 
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The model's ability to predict an influenza pandemic was tested against the existing 
epidemiological data (Fig. 6.4a). The model successfully predicted the average trend 
of H3N2 isolates data in FluNet database of WHO from 1995 to 2006 (Fig. 6.4b). We 
also successfully predicted the fixation rate for dominant and non-dominant epitopes of 
influenza (Fig. 6.5) versus those measured [177]. 
6.5.5 WHO FluNet data analysis 
We acquired the WHO FluNet data for the period of 1995-2006 [180]. We separately 
averaged the isolates data for countries from the Northern and the Southern hemisphere 
over the 1997-2006 seasons [Fig. 6.4a]. For this duration, the annual flu epidemic seems 
to have several peaks. The highest peak occurs in summer. It is interesting to note 
the role played by China, with an incidence peak in the summer, which is very different 
from other Northern hemisphere countries. China probably acts as a reservoir for the 
flu virus and also as a resource for transmission of the virus from pigs to humans in the 
170 
Algeria 
Egypt 
Kenya 
Morroco 
Senegal 
Tunisia 
China 
NorthKorea 
India 
Iran 
Israel 
Japan 
Malaysia 
Mongolia 
Philippines 
SouthKorea 
Singapore 
SriLanka 
r, Thailand 
* ^.Turkey 
* t ^ 0 
Austria 
Belarus 
Belgium 
Bulgaria 
Croatia 
CzechRepublic 
Denmark 
Finland 
France 
Germany , 
Greece 
Hungary 
Iceland 
Ireland 
Italy 
Latvia 
Luxembourg 
Netherlands 
Norway 
Poland 
Portugal 
(0 
•& ;> 0 
S 
» O 
» e 
9 
a) 
Si 
•i 
Romania 
Russia 
(Serbia- Montenegro 
Slovakia 
Slovenia 
Spain 
Sweden 
Switzerland 
Ukraine 
UnitedKingdom 
Canada 
Cuba 
ElSalvador 
Jamaica 
Mexico 
UnitedStates 
Colombia 
FrenchGuiana 
Guyana 
Venezuela 
a 
m 
m 
& m 
•j 
<•> 
• 
* 
* • 
* 
<% & 
* 
T»%t#?8c iilillltalgfigfSli n*™%****t***«*mi'ummi 
< . * * ' 
'1*1111 
T (weeks) 
40 
1 
1 
13 2 0 -
o 
<n 
<D 
a) 2 $ 3 10 
-T 
• ' 
• 
1
 1 ' 1 ' 1 1 ' 1 • 
x WHOFIuNet 
— Simulation 
V xl 
vs. /i 
V ^ t . vXxx V 
i 
-
-
10 20 30 
T (weeks) 40 50 60 
Figure 6.4 Average isolates cases of human H3N2 influenza, (a) Cases reported during last 
10 years for various countries around the world, (b) Comparison between the WHO FluNet 
database and as predicted by our immunological and epidemiological model. 
171 
0.06 
0.05 
0.04 
c 
I 003 
X 
0.02 
0.01-
0 -
X 
+ 
1
 1 
Dominant 
Non-dominant 
Dominant 
Non-dominant 
2.0x10 
g 1.5x10" 
I 1.0x10"= 
5.0x10 
0.0 
100 
1 1 • 1 
-
~ 
-
.,..,, 
.."" 
..-' 
1 
-^' 
1__ 
1 ' 
. . ^ -
~~ 
" 
1 • 
,-"-
100 200 300 
t(day) 
400, 
200 
t (day) 300 
- f 
400 
Figure 6.5 Influenza fixation rate for dominant and non-dominant epitopes. Dominant: 
fixation rate for dominant epitope from simulation, Non-dominant: fixation rate for non- dom-
inant epitopes from simulation; Dominant1: fixation rate and error bar for dominant epitopes 
from sequence analysis [177], Non-dominant1: fixation rate and error bar for non-dominant 
epitope from sequence analysis [177]. 
172 
summer. Thus, the summer peak in China is likely related to the role played by this 
virus reservoir. We aligned the week with the highest peak, weekpeak, to weeki so that 
we could match the burst times for different years. This results in all data from a week 
preceding the peak week being shifted to (weeks2 - weekpeak), and all data from a week 
following the peak week being shifted to (week; - weekpeak). After rearranging the data in 
such manner, we compared the results for average isolates from our simulation with those 
from the WHO FluNet data. A sensitivity analysis was carried out for all the parameters 
involved in Fig. 6.4a. 
6.5.6 Multiple-component vaccine 
We evaluated the viability of using a multiple-component vaccine against simultaneous 
introduction of multiple viral strains. In our model, we considered the possible scenario 
where two initial viruses, differing by e^pitope, cause a pandemic. A pepitope value of zero 
indicates that viruses are the same, whereas apepitope value of 1 indicates that the viruses 
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are completely different. The model then predicted the efficacy of both, single and 
multiple-component vaccines as a function of the e^pitope (Fig. 6.6a). The cumulative 
attack rates are also predicted (Fig. 6.6b). A multiple-component vaccine was found 
to exhibit greater efficacy for the case where multiple-strains are introduced. There 
always exists a lag between viral outbreaks and administration of pertinent vaccine. 
We considered the effect such lag has on single and multiple-component vaccines. It 
was found that the lag affects single-component vaccine more than it affects multiple-
component vaccine (Fig. 6.7a and 6.7 b). 
6.5.7 Population at risk 
In order to manage the risk of possible introduction of multiple strains of avian 
influenza, we combined together our stochastic model and a bioinformatics study. Such 
risk management methods are in common use in financial institutions [181]. In economics, 
Value at Risk (VaR) is used as a metric in risk management studies. The term stands 
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for the maximum loss over a given period of time with a certain confidence level. We 
use an analogous term, Population at Risk (PaR) in our study. It defines the maximum 
percentage of the world's population that is at risk from viral infection in the event of an 
influenza pandemic over the period of one year with a confidence level. As an example, a 
PaR value of 0.1 at the 95% confidence level means that if there are 100 pandemics, the 
maximum percentage of the global population that would be infected by the circulating 
viral strains in 95 of these stands at 0.1. The method could be applied for the risk 
management of infectious diseases in general. In the case of avian influenza, we analyzed 
all H5N1 strains in the National Center for Biotechnology Information (NCBI) database 
[182], and calculated the pepjtoPe f°r aU pairs of the viral strains. The average value 
turned out to be pepitope = 0.118. We generated two initial viruses using the pepitoPe value, 
and carried out simulations for 2000 yearly pandemics for 3 cases: with no vaccination, 
vaccination with single-component vaccine, and vaccination with multiple-component 
vaccine. The PaR was calculated for confidence interval between 0.9 and 0.99. As seen 
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from Fig. 6.8, the fewer the vaccine components, the more the number of people that 
get infected in these pandemics. This clearly shows that a multiple- component vaccine 
not only improves the efficacy of a vaccine, but is also important to manage worse case 
scenarios. 
0.8 T T 
0.6 h 
8l 
Without Vaccine 
Single-Component Vaccine 
Multiple-Component Vaccine 
J_ 
0.92 0.94 0.96 
Confidence Level 
0.98 
Figure 6.8 Population at Risk (PaR) over a year for three cases: without vaccination, 
single-component vaccination, and multiple-component vaccination. 
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6.5.8 Summary 
We have developed a pandemic model for avian influenza. Virus evolution, inter-
personal transmission, vaccination, and immune history are taken into account. The 
model is able to reproduce the observed data for H3N2 isolates. Vaccination against 
multiple-components is not a foregone conclusion in case of simultaneous introduction 
of multiple strains. The parameter pepitope, helps decide if use of multiple-component 
vaccine is likely to be beneficial. The pepitope measure of antigenic distance also helps 
decide what strains to incorporate under such scheme. The model shows that a vac-
cine with multiple- components outperforms a single-component vaccine when there are 
greater than one circulating strains that are antigenically different from each other. The 
model also shows that compared to the traditional single-component vaccine, a multiple-
component vaccine is affected to a lesser degree by the lag between viral outbreak and 
vaccine administration. This result has important implications if there is a sudden at-
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tack of avian influenza pandemic, and the process of designing, producing, delivering, and 
administrating a vaccine is delayed significantly. The model proves that the spread of 
the virus is contingent up on among other things, fraction of the population vaccinated, 
and the time of administration of the vaccine following the outbreak. Lastly, the model 
provides a new parameter PaR that foretells how severe a potential epidemic could be. 
Combined with multiple-component vaccine, PaR will be valuable to alter actual vaccina-
tion strategies, beyond a broad notion of addressing multiple isolates. One can calculate 
daily virus difference through WHO FluNet, and get an average pepitoPe value that could 
be used in our model. The model can yield PaR values for different areas of the World. 
This will alert the policy makers and general public of the current pandemic risk level, 
and also help pharmaceutical companies for preparing optimal vaccine components. An 
improved predictive ability regarding the extent of impending epidemic and appropriate 
vaccine design would enhance our ability to better manage the precious resources. 
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6.6 Sensitivity analysis 
For network structure, we found that the flight distribution is more sensitive than 
population distribution and group distribution (Fig. 6.9 a-c). Although, the initial 
transmission possibility r0 and killing rate cKill affect the cumulative attack rate consid-
erably, they seem to have little effect on the epidemic trend (Fig. 6.10 and Fig. 6.11). 
The immune history capacity seems to have little effect on the epidemic trend as well as 
the cumulative attack rate (Fig. 6.12) . 
We also tested the sensitivity to the mutation rate Rmut a n d cProb. Although both 
of these factors are found to affect the valley of the epidemic trend curve, they do not 
affect cumulative rate or the peak (Fig. 6.13). 
As the last sensitivity test for Fig. 6.4a, we studied the effect of changing the initial 
infected group number (IG). IG has a limited effect on cumulative attack rate and almost 
no effect on the epidemic trend curve (Fig. 6.14). Since fixation rate depends on the 
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mutation and cProb the most, we did sensitivity tests to these two parameters for Fig. 
6.9 (Fig. 6.15). The trend is sensitive to these two factors only in the case of the 
dominant epitope. For non-dominant epitopes, the curve remains flat for different values 
of mutation rates and cProb. 
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